NO142669B - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE, HETEROCYCLIC COMPOUNDS - Google Patents
ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE, HETEROCYCLIC COMPOUNDS Download PDFInfo
- Publication number
- NO142669B NO142669B NO744615A NO744615A NO142669B NO 142669 B NO142669 B NO 142669B NO 744615 A NO744615 A NO 744615A NO 744615 A NO744615 A NO 744615A NO 142669 B NO142669 B NO 142669B
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- dimethoxyphenethyl
- dithian
- propylamine
- tetraoxide
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 18
- 238000002360 preparation method Methods 0.000 title claims description 9
- 150000002391 heterocyclic compounds Chemical class 0.000 title claims description 3
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 98
- -1 benzyloxy, phenyl Chemical group 0.000 claims description 38
- 239000002253 acid Substances 0.000 claims description 33
- 150000003839 salts Chemical class 0.000 claims description 24
- 239000001257 hydrogen Substances 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 125000004434 sulfur atom Chemical group 0.000 claims description 10
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical class 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 229910052727 yttrium Inorganic materials 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 3
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- LERKMAFHYXHGCO-UHFFFAOYSA-N 5-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpentan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCCCC1(C=2C=C(OC)C(OC)=CC=2)SCCCS1 LERKMAFHYXHGCO-UHFFFAOYSA-N 0.000 claims description 2
- ZROUQTNYPCANTN-UHFFFAOYSA-N Tiapamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O ZROUQTNYPCANTN-UHFFFAOYSA-N 0.000 claims description 2
- 125000004423 acyloxy group Chemical group 0.000 claims description 2
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- CQPADMCCOBLYBU-UHFFFAOYSA-N C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=CC(C)=CC=2)S(=O)(=O)CCCS1(=O)=O Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=CC(C)=CC=2)S(=O)(=O)CCCS1(=O)=O CQPADMCCOBLYBU-UHFFFAOYSA-N 0.000 claims 1
- JLHAICPRACKIFB-UHFFFAOYSA-N C=1C=C(OC)C(OC)=CC=1CCN(CC)CCCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O Chemical compound C=1C=C(OC)C(OC)=CC=1CCN(CC)CCCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O JLHAICPRACKIFB-UHFFFAOYSA-N 0.000 claims 1
- VZFKQPFXWPKCEY-UHFFFAOYSA-N N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[2-(4-methoxyphenyl)-1,3-dithian-2-yl]-N-methylpropan-1-amine Chemical compound COC=1C=C(C=CC1OC)CCN(CCCC1(SCCCS1)C1=CC=C(C=C1)OC)C VZFKQPFXWPKCEY-UHFFFAOYSA-N 0.000 claims 1
- YEXYNWAZYPPKQD-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-3-(2-naphthalen-2-yl-1,3-dithian-2-yl)propan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C3C=CC=CC3=CC=2)SCCCS1 YEXYNWAZYPPKQD-UHFFFAOYSA-N 0.000 claims 1
- KYWLWDDYCGVZCY-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-3-(2-phenyl-1,3-dithian-2-yl)propan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=CC=CC=2)SCCCS1 KYWLWDDYCGVZCY-UHFFFAOYSA-N 0.000 claims 1
- CESARNHNESBGSG-UHFFFAOYSA-N n-[2-(4-chlorophenyl)ethyl]-n-methyl-3-(2-phenyl-1,3-dithian-2-yl)propan-1-amine Chemical compound C=1C=C(Cl)C=CC=1CCN(C)CCCC1(C=2C=CC=CC=2)SCCCS1 CESARNHNESBGSG-UHFFFAOYSA-N 0.000 claims 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 148
- 238000002844 melting Methods 0.000 description 117
- 230000008018 melting Effects 0.000 description 117
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 63
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 52
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 51
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 36
- 238000006243 chemical reaction Methods 0.000 description 36
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 34
- 239000000243 solution Substances 0.000 description 34
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 30
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 28
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 239000000203 mixture Substances 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 26
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- 239000000284 extract Substances 0.000 description 19
- 239000002904 solvent Substances 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 17
- HNJWKRMESUMDQE-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-methylethanamine Chemical compound CNCCC1=CC=C(OC)C(OC)=C1 HNJWKRMESUMDQE-UHFFFAOYSA-N 0.000 description 16
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
- 239000007858 starting material Substances 0.000 description 16
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 14
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 14
- 235000019341 magnesium sulphate Nutrition 0.000 description 14
- 230000009467 reduction Effects 0.000 description 14
- 238000006722 reduction reaction Methods 0.000 description 14
- 238000010992 reflux Methods 0.000 description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 12
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 239000002585 base Substances 0.000 description 11
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 11
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 11
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 238000001704 evaporation Methods 0.000 description 10
- 230000008020 evaporation Effects 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 239000003960 organic solvent Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 229960000583 acetic acid Drugs 0.000 description 9
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 229910052783 alkali metal Inorganic materials 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 229910052786 argon Inorganic materials 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 8
- 239000012362 glacial acetic acid Substances 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 8
- ZJLMKPKYJBQJNH-UHFFFAOYSA-N propane-1,3-dithiol Chemical compound SCCCS ZJLMKPKYJBQJNH-UHFFFAOYSA-N 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000012280 lithium aluminium hydride Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- BYSFFOIEDQTZBD-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-1,3-dithiane Chemical compound C1=C(OC)C(OC)=CC=C1C1SCCCS1 BYSFFOIEDQTZBD-UHFFFAOYSA-N 0.000 description 5
- CATQBTMIAAXXND-UHFFFAOYSA-N 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCCCl)S(=O)(=O)CCCS1(=O)=O CATQBTMIAAXXND-UHFFFAOYSA-N 0.000 description 5
- HJBBKVHYQQUPQW-UHFFFAOYSA-N 3-chloro-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine Chemical compound COC1=CC=C(CCN(C)CCCCl)C=C1OC HJBBKVHYQQUPQW-UHFFFAOYSA-N 0.000 description 5
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 5
- YOIBGXUIAJFDER-UHFFFAOYSA-N 4-chloro-3,4-dimethoxy-1-phenylbutan-1-one Chemical compound COC(Cl)C(OC)CC(=O)C1=CC=CC=C1 YOIBGXUIAJFDER-UHFFFAOYSA-N 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 150000004820 halides Chemical class 0.000 description 5
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- GXKPARDRBFURON-UHFFFAOYSA-N 2-phenyl-1,3-dithiane Chemical compound S1CCCSC1C1=CC=CC=C1 GXKPARDRBFURON-UHFFFAOYSA-N 0.000 description 4
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 4
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 4
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000052 vinegar Substances 0.000 description 4
- 235000021419 vinegar Nutrition 0.000 description 4
- ODNGPQOKPLSWSJ-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound C1=C(OC)C(OC)=CC=C1C1S(=O)(=O)CCCS1(=O)=O ODNGPQOKPLSWSJ-UHFFFAOYSA-N 0.000 description 3
- ZYAIFCGRNDAPLN-UHFFFAOYSA-N 2-[[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]methyl]oxirane Chemical compound C1=C(OC)C(OC)=CC=C1C1(CC2OC2)SCCCS1 ZYAIFCGRNDAPLN-UHFFFAOYSA-N 0.000 description 3
- GLVYLTSKTCWWJR-UHFFFAOYSA-N 2-carbonoperoxoylbenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1C(O)=O GLVYLTSKTCWWJR-UHFFFAOYSA-N 0.000 description 3
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- GPEHQHXBPDGGDP-UHFFFAOYSA-N acetonitrile;propan-2-one Chemical compound CC#N.CC(C)=O GPEHQHXBPDGGDP-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 229910052987 metal hydride Inorganic materials 0.000 description 3
- 150000004681 metal hydrides Chemical class 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 150000004965 peroxy acids Chemical class 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- BBWSFUPKOQVSPL-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound O=S1(=O)CCCS(=O)(=O)C1C1=CC=C(OCO2)C2=C1 BBWSFUPKOQVSPL-UHFFFAOYSA-N 0.000 description 2
- FEEDFNKRGAKOFI-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)ethyl-[3-[2-(3,4-dimethoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]propyl]-methylazanium;chloride Chemical compound [Cl-].C1=C(OC)C(OC)=CC=C1CC[NH+](C)CCCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O FEEDFNKRGAKOFI-UHFFFAOYSA-N 0.000 description 2
- ZCVBLOYPBSSBEQ-UHFFFAOYSA-N 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-1,3-dithiane Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCCCl)SCCCS1 ZCVBLOYPBSSBEQ-UHFFFAOYSA-N 0.000 description 2
- QWKZHSATRDJODU-UHFFFAOYSA-N 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-1,3-dithiane 1,3-dioxide Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCCCl)S(=O)CCCS1=O QWKZHSATRDJODU-UHFFFAOYSA-N 0.000 description 2
- HSYKXUHKZHKUQA-UHFFFAOYSA-N 2-(3-chloropropyl)-2-phenyl-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound C=1C=CC=CC=1C1(CCCCl)S(=O)(=O)CCCS1(=O)=O HSYKXUHKZHKUQA-UHFFFAOYSA-N 0.000 description 2
- GIHYCFJFKPVUGQ-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-methylpropan-1-amine Chemical compound C=1C=C(OC)C(OC)=CC=1C1(CCCNC)S(=O)(=O)CCCS1(=O)=O GIHYCFJFKPVUGQ-UHFFFAOYSA-N 0.000 description 2
- NZIYMXRIWYDZGJ-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine;hydrobromide Chemical compound Br.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(OC)C(OC)=CC=2)SCCCS1 NZIYMXRIWYDZGJ-UHFFFAOYSA-N 0.000 description 2
- IXADASBXSLCGOW-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]propanamide Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)CCC1(C=2C=C(OC)C(OC)=CC=2)SCCCS1 IXADASBXSLCGOW-UHFFFAOYSA-N 0.000 description 2
- ASLKIHDOGVHGDY-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]propanoic acid Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCC(O)=O)SCCCS1 ASLKIHDOGVHGDY-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- 241000978776 Senegalia senegal Species 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- WUAXWQRULBZETB-UHFFFAOYSA-N homoveratric acid Chemical compound COC1=CC=C(CC(O)=O)C=C1OC WUAXWQRULBZETB-UHFFFAOYSA-N 0.000 description 2
- 150000007857 hydrazones Chemical class 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- ZSYZSATVCYGOMN-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-3-(1,1,3,3-tetraoxo-2-phenyl-1,3-dithian-2-yl)propan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=CC=CC=2)S(=O)(=O)CCCS1(=O)=O ZSYZSATVCYGOMN-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 229960001412 pentobarbital Drugs 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 235000012976 tarts Nutrition 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 2
- VYMPLPIFKRHAAC-UHFFFAOYSA-N 1,2-ethanedithiol Chemical compound SCCS VYMPLPIFKRHAAC-UHFFFAOYSA-N 0.000 description 1
- WQADWIOXOXRPLN-UHFFFAOYSA-N 1,3-dithiane Chemical compound C1CSCSC1 WQADWIOXOXRPLN-UHFFFAOYSA-N 0.000 description 1
- TUXFRERCSBKURH-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)-4-[(3,4-dimethoxyphenyl)methyl-methylamino]butan-1-one Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCC(=O)C1=CC=C(OC)C(OC)=C1 TUXFRERCSBKURH-UHFFFAOYSA-N 0.000 description 1
- WYGRUZGHYNPZHZ-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)-4-[(3,4-dimethoxyphenyl)methyl-methylamino]butan-1-one;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CN(C)CCCC(=O)C1=CC=C(OC)C(OC)=C1 WYGRUZGHYNPZHZ-UHFFFAOYSA-N 0.000 description 1
- HNWNXPSUKTUCOE-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]pentan-1-one Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCCC(=O)C1=CC=C(OC)C(OC)=C1 HNWNXPSUKTUCOE-UHFFFAOYSA-N 0.000 description 1
- GUZGYERUUISDON-UHFFFAOYSA-N 2-(2,4,5-trimethoxyphenyl)-1,3-dithiane Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C1SCCCS1 GUZGYERUUISDON-UHFFFAOYSA-N 0.000 description 1
- MDUCGIRKSXVGBH-UHFFFAOYSA-N 2-(2-methoxyphenyl)-1,3-dithiane Chemical compound COC1=CC=CC=C1C1SCCCS1 MDUCGIRKSXVGBH-UHFFFAOYSA-N 0.000 description 1
- SWGXZJXVRMFOAW-UHFFFAOYSA-N 2-(3,4,5-trimethoxyphenyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound COC1=C(OC)C(OC)=CC(C2S(CCCS2(=O)=O)(=O)=O)=C1 SWGXZJXVRMFOAW-UHFFFAOYSA-N 0.000 description 1
- BMHGOJAKXOPZBZ-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound C1=C(Cl)C(Cl)=CC=C1C1S(=O)(=O)CCCS1(=O)=O BMHGOJAKXOPZBZ-UHFFFAOYSA-N 0.000 description 1
- FDXCVEPLPKHYGO-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-1,3-dithiolane 1,1,3,3-tetraoxide Chemical compound C1=C(OC)C(OC)=CC=C1C1S(=O)(=O)CCS1(=O)=O FDXCVEPLPKHYGO-UHFFFAOYSA-N 0.000 description 1
- ADRVWTYHWDZXFF-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-2-(oxiran-2-ylmethyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound C1=C(OC)C(OC)=CC=C1C1(CC2OC2)S(=O)(=O)CCCS1(=O)=O ADRVWTYHWDZXFF-UHFFFAOYSA-N 0.000 description 1
- YVDGIIJGINADOP-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-[2-[2-(3,4-dimethoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]ethyl]-n-methylethanamine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=C(OC)C(OC)=CC=C1CCN(C)CCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O YVDGIIJGINADOP-UHFFFAOYSA-N 0.000 description 1
- WDOZKZDAQHLFMB-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-methyl-n-[2-(2-phenyl-1,3-dithian-2-yl)ethyl]ethanamine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCC1(C=2C=CC=CC=2)SCCCS1 WDOZKZDAQHLFMB-UHFFFAOYSA-N 0.000 description 1
- WQEKJSIULSKJLI-UHFFFAOYSA-N 2-(3,4-dimethylphenyl)-1,3-dithiane Chemical compound C1=C(C)C(C)=CC=C1C1SCCCS1 WQEKJSIULSKJLI-UHFFFAOYSA-N 0.000 description 1
- UHLUIHGMQCTEBS-UHFFFAOYSA-N 2-(3,5-dimethoxyphenyl)-1,3-dithiane Chemical compound COC1=CC(OC)=CC(C2SCCCS2)=C1 UHLUIHGMQCTEBS-UHFFFAOYSA-N 0.000 description 1
- DMCWPQRYSHLXSN-UHFFFAOYSA-N 2-(3-bromophenyl)-1,3-dithiane Chemical compound BrC1=CC=CC(C2SCCCS2)=C1 DMCWPQRYSHLXSN-UHFFFAOYSA-N 0.000 description 1
- ISEFIGBHGSPPOI-UHFFFAOYSA-N 2-(3-butoxy-4-methoxyphenyl)-1,3-dithiane Chemical compound C1=C(OC)C(OCCCC)=CC(C2SCCCS2)=C1 ISEFIGBHGSPPOI-UHFFFAOYSA-N 0.000 description 1
- UIZXJJDBVJVNOK-UHFFFAOYSA-N 2-(3-butoxy-4-methoxyphenyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound C1=C(OC)C(OCCCC)=CC(C2S(CCCS2(=O)=O)(=O)=O)=C1 UIZXJJDBVJVNOK-UHFFFAOYSA-N 0.000 description 1
- HVOOEJGCHIRIOP-UHFFFAOYSA-N 2-(3-chlorophenyl)-1,3-dithiane Chemical compound ClC1=CC=CC(C2SCCCS2)=C1 HVOOEJGCHIRIOP-UHFFFAOYSA-N 0.000 description 1
- GBAMSMJCZJOSEY-UHFFFAOYSA-N 2-(3-chloropropyl)-2-phenyl-1,3-dithiane Chemical compound C=1C=CC=CC=1C1(CCCCl)SCCCS1 GBAMSMJCZJOSEY-UHFFFAOYSA-N 0.000 description 1
- RFHQMIDUVXKSTF-UHFFFAOYSA-N 2-(3-methoxy-4-phenylmethoxyphenyl)-1,3-dithiane Chemical compound COC1=CC(C2SCCCS2)=CC=C1OCC1=CC=CC=C1 RFHQMIDUVXKSTF-UHFFFAOYSA-N 0.000 description 1
- QZBJJXMITFWMSS-UHFFFAOYSA-N 2-(3-methoxyphenyl)-1,3-dithiane Chemical compound COC1=CC=CC(C2SCCCS2)=C1 QZBJJXMITFWMSS-UHFFFAOYSA-N 0.000 description 1
- SOQLUIIXIBGXGG-UHFFFAOYSA-N 2-(3-nitrophenyl)-1,3-dithiane Chemical compound [O-][N+](=O)C1=CC=CC(C2SCCCS2)=C1 SOQLUIIXIBGXGG-UHFFFAOYSA-N 0.000 description 1
- PXJPOEWJSVWZIQ-UHFFFAOYSA-N 2-(3-nitrophenyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound [O-][N+](=O)C1=CC=CC(C2S(CCCS2(=O)=O)(=O)=O)=C1 PXJPOEWJSVWZIQ-UHFFFAOYSA-N 0.000 description 1
- DMMIKGLVFJCJDY-UHFFFAOYSA-N 2-(4-chlorophenyl)-1,3-dithiane Chemical compound C1=CC(Cl)=CC=C1C1SCCCS1 DMMIKGLVFJCJDY-UHFFFAOYSA-N 0.000 description 1
- WHKCZNAYJZVBJK-UHFFFAOYSA-N 2-(4-ethoxy-3-methoxyphenyl)-1,3-dithiane Chemical compound C1=C(OC)C(OCC)=CC=C1C1SCCCS1 WHKCZNAYJZVBJK-UHFFFAOYSA-N 0.000 description 1
- IDQGMDVTWFRXOR-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dithiane Chemical compound C1=CC(F)=CC=C1C1SCCCS1 IDQGMDVTWFRXOR-UHFFFAOYSA-N 0.000 description 1
- MGHNHGITZZNUTK-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound C1=CC(F)=CC=C1C1S(=O)(=O)CCCS1(=O)=O MGHNHGITZZNUTK-UHFFFAOYSA-N 0.000 description 1
- DRKUGXIFXHJXGY-UHFFFAOYSA-N 2-(4-methoxy-3-phenylmethoxyphenyl)-1,3-dithiane Chemical compound COC1=CC=C(C2SCCCS2)C=C1OCC1=CC=CC=C1 DRKUGXIFXHJXGY-UHFFFAOYSA-N 0.000 description 1
- BPAHUGKAEMGTSH-UHFFFAOYSA-N 2-(4-methylphenyl)-1,3-dithiane Chemical compound C1=CC(C)=CC=C1C1SCCCS1 BPAHUGKAEMGTSH-UHFFFAOYSA-N 0.000 description 1
- FZWSKAWXRHIBFE-UHFFFAOYSA-N 2-(4-methylphenyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound C1=CC(C)=CC=C1C1S(=O)(=O)CCCS1(=O)=O FZWSKAWXRHIBFE-UHFFFAOYSA-N 0.000 description 1
- NNNDWNVTLKPUSU-UHFFFAOYSA-N 2-(4-phenylphenyl)-1,3-dithiane Chemical compound S1CCCSC1C1=CC=C(C=2C=CC=CC=2)C=C1 NNNDWNVTLKPUSU-UHFFFAOYSA-N 0.000 description 1
- XDJBXINMWLBJAP-UHFFFAOYSA-N 2-(4-propan-2-ylphenyl)-1,3-dithiane Chemical compound C1=CC(C(C)C)=CC=C1C1SCCCS1 XDJBXINMWLBJAP-UHFFFAOYSA-N 0.000 description 1
- OFNAKHBMNBKZRR-UHFFFAOYSA-N 2-(4-propan-2-ylphenyl)-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound C1=CC(C(C)C)=CC=C1C1S(=O)(=O)CCCS1(=O)=O OFNAKHBMNBKZRR-UHFFFAOYSA-N 0.000 description 1
- MNNZINNZIQVULG-UHFFFAOYSA-N 2-chloroethylbenzene Chemical compound ClCCC1=CC=CC=C1 MNNZINNZIQVULG-UHFFFAOYSA-N 0.000 description 1
- ZKKDVLOFLUTRAC-UHFFFAOYSA-N 2-naphthalen-1-yl-1,3-dithiane Chemical compound S1CCCSC1C1=CC=CC2=CC=CC=C12 ZKKDVLOFLUTRAC-UHFFFAOYSA-N 0.000 description 1
- KDQWHJYSSCTXLG-UHFFFAOYSA-N 2-naphthalen-2-yl-1,3-dithiane Chemical compound S1CCCSC1C1=CC=C(C=CC=C2)C2=C1 KDQWHJYSSCTXLG-UHFFFAOYSA-N 0.000 description 1
- PEZBACFBJYOBFK-UHFFFAOYSA-N 2-naphthalen-2-yl-1,3-dithiane 1,1,3,3-tetraoxide Chemical compound O=S1(=O)CCCS(=O)(=O)C1C1=CC=C(C=CC=C2)C2=C1 PEZBACFBJYOBFK-UHFFFAOYSA-N 0.000 description 1
- DSFIBVSDNNYSSO-UHFFFAOYSA-N 2-thiophen-2-yl-1,3-dithiane Chemical compound S1CCCSC1C1=CC=CS1 DSFIBVSDNNYSSO-UHFFFAOYSA-N 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- ANOUKFYBOAKOIR-UHFFFAOYSA-N 3,4-dimethoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1OC ANOUKFYBOAKOIR-UHFFFAOYSA-N 0.000 description 1
- NBQAFNPDUPHRQI-UHFFFAOYSA-N 3-(1,3-dithian-2-yl)benzonitrile Chemical compound N#CC1=CC=CC(C2SCCCS2)=C1 NBQAFNPDUPHRQI-UHFFFAOYSA-N 0.000 description 1
- FCAHGKIONKSNIP-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)-n-[3-[2-(3,4-dimethoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]propyl]-n-methylpropan-1-amine;hydrobromide Chemical compound Br.C1=C(OC)C(OC)=CC=C1CCCN(C)CCCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O FCAHGKIONKSNIP-UHFFFAOYSA-N 0.000 description 1
- INMHFHYATPPOKV-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)-n-[3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]propyl]-n-methylpropan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCCN(C)CCCC1(C=2C=C(OC)C(OC)=CC=2)SCCCS1 INMHFHYATPPOKV-UHFFFAOYSA-N 0.000 description 1
- LXFGWCHPPYFMGW-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)-n-methylpropan-1-amine Chemical compound CNCCCC1=CC=C(OC)C(OC)=C1 LXFGWCHPPYFMGW-UHFFFAOYSA-N 0.000 description 1
- XRBVHVSCKHUGEN-UHFFFAOYSA-N 3-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C3OCCOC3=CC=2)S(=O)(=O)CCCS1(=O)=O XRBVHVSCKHUGEN-UHFFFAOYSA-N 0.000 description 1
- XREQZKVHEPBBDG-UHFFFAOYSA-N 3-[2-(3,4-dichlorophenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(Cl)C(Cl)=CC=2)S(=O)(=O)CCCS1(=O)=O XREQZKVHEPBBDG-UHFFFAOYSA-N 0.000 description 1
- CJXWRMIXGAOZJL-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-methyl-n-[2-(4-methylphenyl)ethyl]propan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1C1(CCCN(C)CCC=2C=CC(C)=CC=2)S(=O)(=O)CCCS1(=O)=O CJXWRMIXGAOZJL-UHFFFAOYSA-N 0.000 description 1
- FRKWGBWWCNXKJO-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dioxo-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)CCCS1=O FRKWGBWWCNXKJO-UHFFFAOYSA-N 0.000 description 1
- USYVIUOQFPWNOA-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(OC)C(OC)=CC=2)SCCCS1 USYVIUOQFPWNOA-UHFFFAOYSA-N 0.000 description 1
- PVFKEOQADCNGFT-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]propan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCNCCCC1(C=2C=C(OC)C(OC)=CC=2)SCCCS1 PVFKEOQADCNGFT-UHFFFAOYSA-N 0.000 description 1
- QEJFRRFZVHQEFF-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]propan-1-amine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=C(OC)C(OC)=CC=C1CCNCCCC1(C=2C=C(OC)C(OC)=CC=2)SCCCS1 QEJFRRFZVHQEFF-UHFFFAOYSA-N 0.000 description 1
- GTEDIZXHRKOJIW-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethylphenyl)ethyl]propanamide Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCC(=O)NCCC=2C=C(C)C(C)=CC=2)SCCCS1 GTEDIZXHRKOJIW-UHFFFAOYSA-N 0.000 description 1
- ZPGWHZGPHPJVCM-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]-n-methylpropan-1-amine Chemical compound C=1C=C(OC)C(OC)=CC=1C1(CCCNC)SCCCS1 ZPGWHZGPHPJVCM-UHFFFAOYSA-N 0.000 description 1
- JAXAPBHKKZHXNS-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)-1,3-dithiolan-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(OC)C(OC)=CC=2)SCCS1 JAXAPBHKKZHXNS-UHFFFAOYSA-N 0.000 description 1
- QXZJQNRNKGRVQH-UHFFFAOYSA-N 3-[2-(3,5-dimethoxyphenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine;oxalic acid Chemical compound OC(=O)C(O)=O.COC1=CC(OC)=CC(C2(CCCN(C)CCC=3C=C(OC)C(OC)=CC=3)SCCCS2)=C1 QXZJQNRNKGRVQH-UHFFFAOYSA-N 0.000 description 1
- ORETZEQGOFKBSF-UHFFFAOYSA-N 3-[2-(3-bromophenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(Br)C=CC=2)S(=O)(=O)CCCS1(=O)=O ORETZEQGOFKBSF-UHFFFAOYSA-N 0.000 description 1
- KXIRVASRGDRDMY-UHFFFAOYSA-N 3-[2-(3-chlorophenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(Cl)C=CC=2)SCCCS1 KXIRVASRGDRDMY-UHFFFAOYSA-N 0.000 description 1
- WRRWSFWPAHMCTI-UHFFFAOYSA-N 3-[2-(4-chlorophenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=CC(Cl)=CC=2)SCCCS1 WRRWSFWPAHMCTI-UHFFFAOYSA-N 0.000 description 1
- BCGYBHKXLPLPEP-UHFFFAOYSA-N 3-chloro-n-[2-(3,4-dimethoxyphenyl)ethyl]-n,2-dimethylpropan-1-amine Chemical compound COC1=CC=C(CCN(C)CC(C)CCl)C=C1OC BCGYBHKXLPLPEP-UHFFFAOYSA-N 0.000 description 1
- GAKKDLWKSVJSJH-UHFFFAOYSA-N 3-chloro-n-methyl-n-(2-phenylethyl)propan-1-amine Chemical compound ClCCCN(C)CCC1=CC=CC=C1 GAKKDLWKSVJSJH-UHFFFAOYSA-N 0.000 description 1
- WSGYTJNNHPZFKR-UHFFFAOYSA-N 3-hydroxypropanenitrile Chemical compound OCCC#N WSGYTJNNHPZFKR-UHFFFAOYSA-N 0.000 description 1
- JPDSDZXASFIXGN-UHFFFAOYSA-N 4-(1,3-dithian-2-yl)-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1SCCCS1 JPDSDZXASFIXGN-UHFFFAOYSA-N 0.000 description 1
- BUAYFJKMVBIPKA-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-4-oxobutanoic acid Chemical compound COC1=CC=C(C(=O)CCC(O)=O)C=C1OC BUAYFJKMVBIPKA-UHFFFAOYSA-N 0.000 description 1
- OUXKXUDAWIAOSX-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-N-[3-[2-(3,4-dimethoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]propyl]-N-methylbutan-2-amine Chemical compound COC=1C=C(C=CC=1OC)C1(S(CCCS1(=O)=O)(=O)=O)CCCN(C)C(CCC1=CC(=C(C=C1)OC)OC)C OUXKXUDAWIAOSX-UHFFFAOYSA-N 0.000 description 1
- JJQXPCRQRSSRFG-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-n-methyl-n-[3-[1,1,3,3-tetraoxo-2-(4-propan-2-ylphenyl)-1,3-dithian-2-yl]propyl]butan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCCCN(C)CCCC1(C=2C=CC(=CC=2)C(C)C)S(=O)(=O)CCCS1(=O)=O JJQXPCRQRSSRFG-UHFFFAOYSA-N 0.000 description 1
- GEUWWCMOFIKLMO-UHFFFAOYSA-N 4-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylbutan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCCC1(C=2C=C(OC)C(OC)=CC=2)SCCCS1 GEUWWCMOFIKLMO-UHFFFAOYSA-N 0.000 description 1
- XXJRXPXDARDZLG-UHFFFAOYSA-N 4-[2-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-1,3-dithian-2-yl]-n,n-dimethylaniline;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=CC(=CC=2)N(C)C)SCCCS1 XXJRXPXDARDZLG-UHFFFAOYSA-N 0.000 description 1
- IPLKGJHGWCVSOG-UHFFFAOYSA-N 4-chlorobutanoic acid Chemical compound OC(=O)CCCCl IPLKGJHGWCVSOG-UHFFFAOYSA-N 0.000 description 1
- DMJZKGGHTJZDBW-UHFFFAOYSA-N 5-(1,3-dithian-2-yl)-1,3-benzodioxole Chemical compound C1=C2OCOC2=CC=C1C1SCCCS1 DMJZKGGHTJZDBW-UHFFFAOYSA-N 0.000 description 1
- DPQOHINLXWJCFQ-UHFFFAOYSA-N 6-(1,3-dithian-2-yl)-2,3-dihydro-1,4-benzodioxine Chemical compound S1CCCSC1C1=CC=C(OCCO2)C2=C1 DPQOHINLXWJCFQ-UHFFFAOYSA-N 0.000 description 1
- LLSNYRNWSPUIOS-UHFFFAOYSA-N 6-chloro-1-(3,4-dimethoxyphenyl)hexan-1-one Chemical compound COC1=CC=C(C(=O)CCCCCCl)C=C1OC LLSNYRNWSPUIOS-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- MRDHYAQXANGMCE-UHFFFAOYSA-N C(C(=O)O)(=O)O.COC=1C=C(C=CC1OC)CCN(C(CC1(S(CCC(S1(=O)=O)C)(=O)=O)C1=CC(=C(C=C1)OC)OC)O)C Chemical compound C(C(=O)O)(=O)O.COC=1C=C(C=CC1OC)CCN(C(CC1(S(CCC(S1(=O)=O)C)(=O)=O)C1=CC(=C(C=C1)OC)OC)O)C MRDHYAQXANGMCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- GAQLJKMCPSPQOC-UHFFFAOYSA-N Cl.COC=1C=C(C=CC1OC)CCN(CCCC1(S(CCCS1(=O)=O)(=O)=O)C1=CC=C(C=C1)C(C)C)C Chemical compound Cl.COC=1C=C(C=CC1OC)CCN(CCCC1(S(CCCS1(=O)=O)(=O)=O)C1=CC=C(C=C1)C(C)C)C GAQLJKMCPSPQOC-UHFFFAOYSA-N 0.000 description 1
- ONLZTLVLWTZLLN-UHFFFAOYSA-N Cl.COC=1C=C(CCN(CCCC2(SCCCS2)C2=CC=C(C=C2)OC)C)C=CC1OC Chemical compound Cl.COC=1C=C(CCN(CCCC2(SCCCS2)C2=CC=C(C=C2)OC)C)C=CC1OC ONLZTLVLWTZLLN-UHFFFAOYSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N Cyclohexane Natural products CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- FRMRJNSQKUPPSH-UHFFFAOYSA-N OC(=O)C(O)=O.C1=C(OC)C(OC)=CC=C1CCN(C)CCCCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O Chemical compound OC(=O)C(O)=O.C1=C(OC)C(OC)=CC=C1CCN(C)CCCCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O FRMRJNSQKUPPSH-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 101150046432 Tril gene Proteins 0.000 description 1
- 238000005644 Wolff-Kishner reduction reaction Methods 0.000 description 1
- FKCBLVCOSCZFHV-UHFFFAOYSA-N acetonitrile;ethanol Chemical compound CCO.CC#N FKCBLVCOSCZFHV-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000005011 alkyl ether group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- WVHBHPATSLQXGC-UHFFFAOYSA-N benzene;ethanol Chemical compound CCO.C1=CC=CC=C1 WVHBHPATSLQXGC-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- FHHZOYXKOICLGH-UHFFFAOYSA-N dichloromethane;ethanol Chemical compound CCO.ClCCl FHHZOYXKOICLGH-UHFFFAOYSA-N 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000004887 dithianes Chemical class 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 125000005905 mesyloxy group Chemical group 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- RHMQNXNXUZLEIY-UHFFFAOYSA-N methanol;2-propan-2-yloxypropane Chemical compound OC.CC(C)OC(C)C RHMQNXNXUZLEIY-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- XTSJNYJEVRCAEG-UHFFFAOYSA-N n-(2-chloroethyl)-2-(3,4-dimethoxyphenyl)-n-methylethanamine Chemical compound COC1=CC=C(CCN(C)CCCl)C=C1OC XTSJNYJEVRCAEG-UHFFFAOYSA-N 0.000 description 1
- HJEGNVDKNXPESQ-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-3-[2-(2-methoxy-5-methylphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C(=CC=C(C)C=2)OC)S(=O)(=O)CCCS1(=O)=O HJEGNVDKNXPESQ-UHFFFAOYSA-N 0.000 description 1
- ADZUFQWKDVRYKL-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-3-[2-(2-methoxyphenyl)-1,3-dithian-2-yl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C(=CC=CC=2)OC)SCCCS1 ADZUFQWKDVRYKL-UHFFFAOYSA-N 0.000 description 1
- BVFMZQKZORYMMS-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-3-[2-(3,4-dimethylphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(C)C(C)=CC=2)S(=O)(=O)CCCS1(=O)=O BVFMZQKZORYMMS-UHFFFAOYSA-N 0.000 description 1
- KMRPJEFZXKJKBO-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-3-[2-(3-methoxy-4-phenylmethoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-methylpropan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C(OC)C(OCC=3C=CC=CC=3)=CC=2)S(=O)(=O)CCCS1(=O)=O KMRPJEFZXKJKBO-UHFFFAOYSA-N 0.000 description 1
- JLHUTWRIPVISTP-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-3-[2-(4-ethoxy-3-methoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OCC)=CC=C1C1(CCCN(C)CCC=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O JLHUTWRIPVISTP-UHFFFAOYSA-N 0.000 description 1
- FSNOGFLLVVBQQY-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-3-[2-(4-fluorophenyl)-1,3-dithian-2-yl]-n-methylpropan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=CC(F)=CC=2)SCCCS1 FSNOGFLLVVBQQY-UHFFFAOYSA-N 0.000 description 1
- FQIPZZJLYBBPKW-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-5-[2-(3,4-dimethoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]-n-methylpentan-1-amine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=C(OC)C(OC)=CC=C1CCN(C)CCCCCC1(C=2C=C(OC)C(OC)=CC=2)S(=O)(=O)CCCS1(=O)=O FQIPZZJLYBBPKW-UHFFFAOYSA-N 0.000 description 1
- QKKXXHXZYPNBSX-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-3-(2-naphthalen-2-yl-1,3-dithian-2-yl)propan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=C3C=CC=CC3=CC=2)SCCCS1 QKKXXHXZYPNBSX-UHFFFAOYSA-N 0.000 description 1
- JRDMPXLLFKYYHX-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-3-(2-phenyl-1,3-dithian-2-yl)propan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=CC=CC=2)SCCCS1 JRDMPXLLFKYYHX-UHFFFAOYSA-N 0.000 description 1
- ZJRYLKXASAOAHO-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-3-(2-thiophen-2-yl-1,3-dithian-2-yl)propan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2SC=CC=2)SCCCS1 ZJRYLKXASAOAHO-UHFFFAOYSA-N 0.000 description 1
- CQCGVYAMKCVRHZ-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-3-[2-(2,4,5-trimethoxyphenyl)-1,3-dithian-2-yl]propan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C(=CC(OC)=C(OC)C=2)OC)SCCCS1 CQCGVYAMKCVRHZ-UHFFFAOYSA-N 0.000 description 1
- QASRZNOZHWAOGF-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-3-[2-(4-methylphenyl)-1,3-dithian-2-yl]propan-1-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCN(C)CCCC1(C=2C=CC(C)=CC=2)SCCCS1 QASRZNOZHWAOGF-UHFFFAOYSA-N 0.000 description 1
- AKLWRESOMZNOJS-UHFFFAOYSA-N n-[3-[2-(3,4-dimethoxyphenyl)-1,1,3,3-tetraoxo-1,3-dithian-2-yl]propyl]-n-methyl-1-phenylpropan-2-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1C1(CCCN(C)C(C)CC=2C=CC=CC=2)S(=O)(=O)CCCS1(=O)=O AKLWRESOMZNOJS-UHFFFAOYSA-N 0.000 description 1
- PXWTYUCXZVVCPL-UHFFFAOYSA-N n-[3-[2-(3,4-dimethoxyphenyl)-1,3-dithian-2-yl]propyl]-n-methyl-1-phenylpropan-2-amine Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCCN(C)C(C)CC=2C=CC=CC=2)SCCCS1 PXWTYUCXZVVCPL-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- FRBRFYBPKXAXLW-UHFFFAOYSA-N n-methyl-n-(2-phenylethyl)-3-(1,1,3,3-tetraoxo-2-phenyl-1,3-dithian-2-yl)propan-1-amine;hydrochloride Chemical compound Cl.C=1C=CC=CC=1CCN(C)CCCC1(C=2C=CC=CC=2)S(=O)(=O)CCCS1(=O)=O FRBRFYBPKXAXLW-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229940117803 phenethylamine Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- NCNISYUOWMIOPI-UHFFFAOYSA-N propane-1,1-dithiol Chemical compound CCC(S)S NCNISYUOWMIOPI-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical class OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Description
Nærværende oppfinnelse vedrører analogifremgangsmåte for fremstilling av terapeutisk virksomme, heterocykliske forbindelser med den generelle formel The present invention relates to an analogous method for the preparation of therapeutically active, heterocyclic compounds with the general formula
hvor R betyr en rest med formelen where R means a residue with the formula
hvori 1^, R2 og betyr hydrogen, halogen, lavere alkyl, lavere alkoksy, benzyloksy, fenyl, nitro, tri-fluormetyl, hydroksy, cyano, di-lavere alkylamino wherein 1^, R2 and means hydrogen, halogen, lower alkyl, lower alkoxy, benzyloxy, phenyl, nitro, trifluoromethyl, hydroxy, cyano, di-lower alkylamino
eller lavere alkanoyloksy eller to rester i nabostilling sammen metylendioksy, etylendioksy eller butadien-1,3-ylen-l,4, or lower alkanoyloxy or two residues in a neighboring position together methylenedioxy, ethylenedioxy or butadiene-1,3-ylen-1,4,
R4 betyr hydrogen eller lavere alkyl, R4 means hydrogen or lower alkyl,
R,., Rg og R7 betyr hydrogen, halogen, lavere alkyl, eller lavere alkoksy eller to rester i nabostilling sammen metylendioksy eller etylendioksy, R,., Rg and R7 mean hydrogen, halogen, lower alkyl, or lower alkoxy or two residues in a neighboring position together methylenedioxy or ethylenedioxy,
X betyr et svovelatom, SO eller SO,,, X means a sulfur atom, SO or SO,,,
Y betyr en rettkjedet eller forgrenet, eventuelt Y means a straight chain or branched, optionally
med hydroksy substituert, alkylenrest med 2-5 karbonatomer, og with hydroxy substituted, alkylene residue with 2-5 carbon atoms, and
Z betyr en rettkjedet eller forgrenet, eventuelt med hydroksy substituert, alkylenrest med 1-4 karbonatomer , og Z means a straight-chain or branched, optionally substituted with hydroxy, alkylene residue with 1-4 carbon atoms, and
m er tallene 0 eller 1 og m are the numbers 0 or 1 and
n tallene 2 eller 3, hvorunder de "lavere" rester inneholder 1-6 karbonatomer n the numbers 2 or 3, under which the "lower" residues contain 1-6 carbon atoms
og syreaddisjonssalter herav. and acid addition salts thereof.
Fra det tyske utlegningsskrift nr. 1.154.810 og DOS nr. 2.000.435 er kjent strukturelt beslektede forbindelser som likeledes har coronardilatoriske egenskaper som kalsium-antagonister. Disse forbindelser er dog belastet med sterk-ere og langvarig hypotensiv og negativ-ionotrop virkning, altså med bivirkninger, som kan være klinisk uheldige. Til forskjell fra disse har forbindelsene som fremstilles ifølge foreliggende oppfinnelse ikke disse negative egenskaper, men har tvert imot også gode anti-arytimiske egenskaper med god fordragelighet. Structurally related compounds are known from the German explanatory document no. 1,154,810 and DOS no. 2,000,435 which likewise have coronary dilatatory properties as calcium antagonists. However, these compounds are burdened with stronger and longer-lasting hypotensive and negative-ionotropic effects, i.e. with side effects, which can be clinically unfortunate. In contrast to these, the compounds produced according to the present invention do not have these negative properties, but on the contrary also have good anti-arrhythmic properties with good tolerability.
Uttrykket "lavere alkyl" betyr innenfor rammen av nærværende oppfinnelse rettkjedete eller forgrenede alkylgrupper med 1 - 6 karbonatomer, som f.eks. metyl, etyl, n-propyl, isopropyl, n-butyl, isobutyl, tert. butyl, amyl, heksyl. The term "lower alkyl" within the scope of the present invention means straight-chain or branched alkyl groups with 1-6 carbon atoms, such as e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert. butyl, amyl, hexyl.
"Lavere alkoksy" betyr lavere alkyletergrupper, hvor uttrykket "lavere alkyl" har forannevnte betydning. "Halogen" omfatter de 4 halogenatomer fluor, klor, brom og jod. "Lavere alkanoyl" betyr alkanoylgrupper med inntil 6 karbonatomer, som f.eks. formyl, acetyl, propionyl, butyryl. "Aryl" betyr usubstituert eller substituert fenyl, idet som substituenter er å forstå halogen, lavere alkyl, lavere alkoksy, nitro og amino. Det i det etterfolgende anvendte uttrykk "uttredende gruppe" betyr innenfor rammen av nærværende oppfinnelse, kjente grupper som f.eks. halogen, fortrinnsvis brom eller klor, arylsulfonyloksy, som f.eks. tosyloksy, alkylsulfonyloksy som f.eks. mesyloksy eller også en epoksygruppe., "Lower alkoxy" means lower alkyl ether groups, where the term "lower alkyl" has the aforesaid meaning. "Halogen" includes the 4 halogen atoms fluorine, chlorine, bromine and iodine. "Lower alkanoyl" means alkanoyl groups with up to 6 carbon atoms, such as e.g. formyl, acetyl, propionyl, butyryl. "Aryl" means unsubstituted or substituted phenyl, the substituents being halogen, lower alkyl, lower alkoxy, nitro and amino. The term "leaving group" used in the following means, within the scope of the present invention, known groups such as e.g. halogen, preferably bromine or chlorine, arylsulphonyloxy, such as e.g. tosyloxy, alkylsulfonyloxy such as e.g. mesyloxy or also an epoxy group.,
Fremgangsmåten ifolge nærværende oppfinnelse for fremstilling av forbindelsene av foranstående formel I og disses salter er karakterisert ved at man The method according to the present invention for preparing the compounds of the above formula I and their salts is characterized by
a) omsetter en forbindelse av den generelle formel a) reacts with a compound of the general formula
hvor R, X og n har foran angitte betydninger, med en forbindelse av den generelle formel where R, X and n have the above meanings, with a compound of the general formula
hvor R ^ • - Ry, Yy Z og m har de forannevnte betyd- 'j ninger, og where R ^ • - Ry, Yy Z and m have the aforementioned meanings, and
Rg betyr en avspaltbar gruppe såsom halogen, arylsulfonyloksy eller alkylsulfonyloksy Rg means a leaving group such as halogen, arylsulfonyloxy or alkylsulfonyloxy
eller or
b) omsetter en forbindelse av den generelle formel b) reacts with a compound of the general formula
hvor R, R4 - R7, Y, Z og m har foran angitte where R, R4 - R7, Y, Z and m are previously indicated
betydning, importance,
med en forbindelse av den generelle formel with a compound of the general formula
hvor n har foran angitte betydning, where n has the above meaning,
eller or
c) omsetter en forbindelse av den generelle formel c) reacts with a compound of the general formula
hvor R, Rg, X, Y og n har foran angitte where R, Rg, X, Y and n have previously been specified
betydninger, meanings,
med en forbindelse av den generelle formel with a compound of the general formula
hvor R^ - R7, Z og m har de foran angitte betydninger , where R^ - R7, Z and m have the previously stated meanings,
eller or
d) omsetter en forbindelse av den generelle formel d) reacts with a compound of the general formula
hvor R, R^, X, Y og n har de foran angitte where R, R^, X, Y and n have those indicated above
betydninger, meanings,
med en forbindelse av den generelle formel with a compound of the general formula
hvor R,- - Rg, Z og m har de foran angitte where R, - - Rg, Z and m have those indicated above
betydninger, meanings,
eller or
e) i en forbindelse av den generelle formel e) in a compound of the general formula
hvori R, R4 -■R7, X, Y, Z, m og n har den foran' angitte betydning, in which R, R4 -■R7, X, Y, Z, m and n have the previously stated meaning,
Y. og Z^ er en gruppe som tilsvarer Y hhv. Z idet Y. and Z^ is a group corresponding to Y and respectively. Z at the time
minst en av gruppene Y^ og Z^ inneholder en karbonylgruppe og R^, betyr hydrogen eller en alkylgruppe med 1-5 karbonatomer, at least one of the groups Y^ and Z^ contains a carbonyl group and R^ means hydrogen or an alkyl group with 1-5 carbon atoms,
reduserer karbonylgruppen reduces the carbonyl group
hvoretter man, hvis ønsket, oksyderer en forbindelse med formel I, hvori X betyr et svovelatom, til en forbindelse med formel I, hvori X betyr. So eller SO^, at man, hvis ønsket, N-lavere-alkylerer en forbindelse med formel T,'hvori R^ betyr hydrogen, at man, hvis ønsket, overfører en lavere alkoksy- eller benzyloksy- til en hydroksygruppe, at man, hvis ønsket, foretrer eller forestrer en hydroksygruppe med en lavere alkankarbonsyre og, at man, hvis ønsket, overfører en erholdt base til et -syreaddisjonssalt. after which, if desired, a compound of formula I, in which X represents a sulfur atom, is oxidized to a compound of formula I, in which X represents. So or SO^, that one, if desired, N-lower-alkylates a compound of formula T,' in which R^ means hydrogen, that one, if desired, transfers a lower alkoxy- or benzyloxy- to a hydroxy group, that one, if desired, etherifying or esterifying a hydroxy group with a lower alkanecarboxylic acid and, if desired, transferring a base obtained to an -acid addition salt.
Foretrukne, under foranstående formel I fallende forbindelser er de forbindelser som fremstilles ifølge krav 2-10 og hvis spesielle virkning fremgår av de senere angitte tabeller I og Preferred compounds falling under the preceding formula I are the compounds which are prepared according to claims 2-10 and whose special effect is evident from the later specified tables I and
II- II-
Omsetningen av en forbindelse av formel II med en forbindelse av formel III kan gjennomføres på i og for seg kjent måte. Hensiktsmessig skjer reaksjonen i et, under reaksjonsbetingelsene inert, organisk opplosningsmiddel og ved en temperatur mellom ca. -80°C og reaksjonsblandingens tilbakelopstemperatur, fortrinnsvis mellom 0 og 50°C og særlig ved romtemperatur. Som opplosningsmidler kan nevnes etere som f.eks. dietyleter, The reaction of a compound of formula II with a compound of formula III can be carried out in a manner known per se. Appropriately, the reaction takes place in an, under the reaction conditions inert, organic solvent and at a temperature between approx. -80°C and the reflux temperature of the reaction mixture, preferably between 0 and 50°C and in particular at room temperature. Ethers such as e.g. diethyl ether,
tetrahydrofuran, dioksan, aromatiske hydrokarboner, tetrahydrofuran, dioxane, aromatic hydrocarbons,
som f.eks. benzen, toluen, xylen eller også dimetylformamid, dimetylsulfoksyd. Reaksjonen skjer i nsrvær like for example. benzene, toluene, xylene or also dimethylformamide, dimethylsulphoxide. The reaction takes place in nsrvær
av en sterk base som f.eks. butyllitium, en Grignard-forbindelse, natrium eller natriumhydrid, hvorved, hvis X er et svovelatom, hensiktsmessig en særlig sterk base som butyllitium eller en Grignard-forbindelse fanvendes. of a strong base such as butyllithium, a Grignard compound, sodium or sodium hydride, whereby, if X is a sulfur atom, suitably a particularly strong base such as butyllithium or a Grignard compound is used.
De som utgangsmaterialer anvendte forbindelser av foranstående formler II og III er delvis kjente og delvis nye. De nye forbindelser er likeledes gjenstand for oppfinnelsen. De kan fremstilles på i og for seg kjent måte, d.v.s. på for fremstillingen av de kjente forbindelser analog måte. The compounds of the preceding formulas II and III used as starting materials are partly known and partly new. The new compounds are likewise subject to the invention. They can be produced in a manner known per se, i.e. in a manner analogous to the preparation of the known compounds.
De forbindelser av formel II, hvor X er et svovelatom, kan f. eks. oppnås ved omsetning av et aldehyd av formlen The compounds of formula II, where X is a sulfur atom, can e.g. is obtained by reacting an aldehyde of the formula
hvor R har foranstående betydning, where R has the preceding meaning,
med etan- eller propanditiol. Omsetningen skjer hensiktsmessig i et inert organisk opplosningsmiddel, f.eks. kloroform under romtemperatur. with ethane or propane dithiol. The reaction conveniently takes place in an inert organic solvent, e.g. chloroform under room temperature.
De forbindelser av formel II, hvor X betyr SO eller SO2, kan oppnås ved oksydasjon av tilsvarende forbindelser, hvor X er et svovelatom. Oksydasjonen kan hensiktsmessig skje i et egnet opplosningsmiddel, ved hjelp av persyre som pereddiksyre, perftalsyre, m-klor-perbenzosyre. Pereddiksyre kan f.eks. dannes in situ fra iseddik og hydrogensuperoksyd. The compounds of formula II, where X means SO or SO2, can be obtained by oxidation of corresponding compounds, where X is a sulfur atom. The oxidation can conveniently take place in a suitable solvent, using peracids such as peracetic acid, perphthalic acid, m-chloro-perbenzoic acid. Peracetic acid can e.g. is formed in situ from glacial acetic acid and hydrogen peroxide.
Omsetningen av en forbindelse av formel IV med en forbindelse av formel V kan gjennomfores på i og for seg kjente måte. Hensiktsmessig skjer reaksjonen i et, under reaksjonsbetingelsene inert, organisk opplosningsmiddel, fortrinnsvis i et polart opplosningsmiddel som halogenerte hydrokarboner, f.eks. kloroform, metylenklorid, eller i etylenglykoldimetyl- The reaction of a compound of formula IV with a compound of formula V can be carried out in a manner known per se. Appropriately, the reaction takes place in an, under the reaction conditions inert, organic solvent, preferably in a polar solvent such as halogenated hydrocarbons, e.g. chloroform, methylene chloride, or in ethylene glycol dimethyl-
eter o.s.v.. Reaksjonen skjer også hensiktsmessig i nærvær av et vannavspaltende middel, som f.eks. svovelsyre, halogenhydro-gensyre, fosforsyre og ved en temperatur mellom ca. 0°C og reaksjonsblandingens tilbakelopstemperatur, fortrinnsvis ved romtemperatur. ether, etc. The reaction also conveniently takes place in the presence of a water-splitting agent, such as e.g. sulfuric acid, hydrohalic acid, phosphoric acid and at a temperature between approx. 0°C and the reflux temperature of the reaction mixture, preferably at room temperature.
De som utgangsmaterialer anvendte forbindelser av formel V The compounds of formula V used as starting materials
er kjente og kan fremstilles på kjent måte. are known and can be produced in a known manner.
De som utgangsmaterialer anvendte forbindelser av formel IV er nye. The compounds of formula IV used as starting materials are new.
Forbindelsene av formel IV kan f.eks. fremstilles ved at man omsetter en forbindelse av den generelle formel The compounds of formula IV can e.g. is produced by reacting a compound of the general formula
hvor R og Y har foranstående betydninger, med en forbindelse av den generelle formel where R and Y have the preceding meanings, with a compound of the general formula
hvor R^ -Ry, Z og m har foran angitte betydninger .. where R^ -Ry, Z and m have the above meanings..
Omsetningen skjer hensiktsmessig i nærvær av et syrebindende middel, som f.eks. et tert. amin, f.eks. N-etyl-N,N-diisopro-pylamin, som samtidig tjener som opplosningsmiddel. Reaksjonen, skjer også hensiktsmessig ved forhoyet temperatur, fortrinnsvis ved en temperatur på inntil ca. 130°C, avhengig av opplosnings-midlets kokepunkt. The conversion conveniently takes place in the presence of an acid-binding agent, such as e.g. a tart. amine, e.g. N-ethyl-N,N-diisopropylamine, which also serves as a solvent. The reaction also suitably takes place at an elevated temperature, preferably at a temperature of up to approx. 130°C, depending on the boiling point of the solvent.
De foran anvendte forbindelser av formlen XlVa er delvis kjente og delvis nye. De kan fremstilles på i og for seg kjent måte, d.v.s. på for fremstillingen av kjente forbindelser analog måte. Forbindelsene av formel VII er kjente. The compounds of formula XlVa used above are partly known and partly new. They can be produced in a manner known per se, i.e. in a manner analogous to the preparation of known compounds. The compounds of formula VII are known.
Omsetningen av en forbindelse av formel VI med en forbindelse av formel VII kan gjennomføres på i og for seg kjent måte. Hensiktsmessig skjer omsetningen i et, under reaksjonsbetingelsene inert, organisk opplosningsmiddel, som en eter, f.eks. dibutyleter, dioksan, tetrahydrofuran, en alkanol som f.eks. etanol eller propanol, et aromatisk hydrokarbon som f.eks. benzen, toluen eller xylen eller også i acetonitril, dimetylformamid, dimetylsulfoksyd . Reaksjonen kan gjennom- The reaction of a compound of formula VI with a compound of formula VII can be carried out in a manner known per se. Appropriately, the reaction takes place in an, under the reaction conditions inert, organic solvent, such as an ether, e.g. dibutyl ether, dioxane, tetrahydrofuran, an alkanol such as e.g. ethanol or propanol, an aromatic hydrocarbon such as benzene, toluene or xylene or also in acetonitrile, dimethylformamide, dimethylsulfoxide. The reaction can through-
føres ved en temperatur mellom ca. romtemperatur og reaksjons- carried out at a temperature between approx. room temperature and reaction
blandingens tilbakelopstemperatur. Fortrinnsvis arbeides det ved tilbakelopstemperatur. Hvis ved omsetningen syre'avspaltes skjer dette hensiktsmessig i nærvær av en base, f.eks. et tert. amin som f.eks. trimetylamin, N-etyl-N,N-diisopropylamin eller N,N-dimetylanilin. the reflux temperature of the mixture. Preferably, work is carried out at reflux temperature. If acid is split off during the reaction, this conveniently happens in the presence of a base, e.g. a tart. amine such as e.g. trimethylamine, N-ethyl-N,N-diisopropylamine or N,N-dimethylaniline.
De som utgangsmateriale anvendte forbindelser av formel VII The compounds of formula VII used as starting material
er kjente. Forbindelsene av formel VI er imidlertid nye. Forbindelsene av formel VI kan f.eks. fremstilles ved at man omsetter en forbindelse av formel are known. However, the compounds of formula VI are new. The compounds of formula VI can e.g. is produced by reacting a compound of formula
hvor R, Rg og Y har foran angitte betydninger, med en forbindelse av formel where R, Rg and Y have the above meanings, with a compound of formula
hvor n har foran angitte betydning, where n has the above meaning,
og hvis onsket overforer en slik erholdt forbindelse av formel VI, hvor X betyr et svovelatom, ved oksydasjon til en forbindelse av formel VI, hvor X betyr SO eller S02-and, if desired, transfers such an obtained compound of formula VI, where X means a sulfur atom, by oxidation to a compound of formula VI, where X means SO or SO2-
Omsetningen av en forbindelse av formel XIV med en forbindelse av formel V kan gjennomfores på i og for seg kjent måte. Hensiktsmessig skjer reaksjonen i et under reaksjonsbetingelsene inert, organisk opplosningsmiddel, fortrinnsvis i et polart opplosningsmiddel som halogenerte hydrokarboner, f.eks. kloroform, metylenklorid eller i etylenglykoldimetyl eter. Reaksjonen skjer også hensiktsmessig i nærvær av et vannavspaltende middel, som f.eks. svovelsyre, halogen-hydrogensyre, fosforsyre og ved en temperatur mellom ca. 0°C og reaksjonsblandingens tilbakelopstemperatur, fortrinnsvis ved romtemperatur. The reaction of a compound of formula XIV with a compound of formula V can be carried out in a manner known per se. Appropriately, the reaction takes place in an organic solvent that is inert under the reaction conditions, preferably in a polar solvent such as halogenated hydrocarbons, e.g. chloroform, methylene chloride or in ethylene glycol dimethyl ether. The reaction also conveniently takes place in the presence of a water-splitting agent, such as e.g. sulfuric acid, halogen-hydrogen acid, phosphoric acid and at a temperature between approx. 0°C and the reflux temperature of the reaction mixture, preferably at room temperature.
Overforingen av en slik erholdt forbindelse av formel VI, hvor X er et svovelatom, til en forbindelse, hvor X er SO eller S02, kan skje på i og for seg kjent måte, f.eks. ved oksydasjon med en persyre som f.eks. pereddiksyre, perftalsyre, m-klorperbenzosyre. Pereddiksyre kan f.eks. dannes in situ fra iseddik og hydrogensuperoksyd. The transfer of a compound of formula VI obtained in this way, where X is a sulfur atom, to a compound where X is SO or SO 2 can take place in a manner known per se, e.g. by oxidation with a peracid such as e.g. peracetic acid, perphthalic acid, m-chloroperbenzoic acid. Peracetic acid can e.g. is formed in situ from glacial acetic acid and hydrogen peroxide.
Omsetningen av en forbindelse av formel X med en forbindelse av formel XI kan gjennomfores på i og for seg kjent måte. Hensiktsmessig skjer omsetningen i et under reaksjonsbetingelsene inert, organisk opplosningsmiddel som en eter, f.eks. dibutyleter, dioksan, tetrahydrofuran, en alkanol som f.eks. etanol eller propanol,et aromatisk hydrokarbon som f.eks. benzen, toluen eller xylen eller også i acetonitril, dimetylformamid, dimetylsulfoksyd. Reaksjonen kan gjennomføres ved en temperatur mellom ca. romtemperatur og reaksjonsblandingens tilbakelopstemperatur. Fortrinnsvis arbeides ved tilbakelopstemperatur. Hvis ved omsetningen syren spaltes av skjer dette hensiktsmessig i nærvær av en base, f.eks. et tertiært amin som f.eks. trietylamin, N-etyl-N,N-diisopropylamin eller N,N-dimetylanilin. The reaction of a compound of formula X with a compound of formula XI can be carried out in a manner known per se. Appropriately, the reaction takes place in an organic solvent that is inert under the reaction conditions, such as an ether, e.g. dibutyl ether, dioxane, tetrahydrofuran, an alkanol such as e.g. ethanol or propanol, an aromatic hydrocarbon such as e.g. benzene, toluene or xylene or also in acetonitrile, dimethylformamide, dimethylsulfoxide. The reaction can be carried out at a temperature between approx. room temperature and the reflux temperature of the reaction mixture. Preferably work at reflux temperature. If during the reaction the acid is split off, this conveniently happens in the presence of a base, e.g. a tertiary amine such as triethylamine, N-ethyl-N,N-diisopropylamine or N,N-dimethylaniline.
De som utgangsmaterialer anvendte forbindelser av formel XI They used compounds of formula XI as starting materials
er kjente. Forbindelsene av formel X er imidlertid nye. are known. However, the compounds of formula X are new.
Forbindelsene av formel X kan f.eks. fremstilles ved at man omsetter en forbindelse av formel The compounds of formula X can e.g. is produced by reacting a compound of formula
hvor R, X, Y og n har foran angitte betydninger, where R, X, Y and n have the above meanings,
med et amin av formlen with an amine of the formula
hvor R4 har foran angitte betydning . where R4 has the above meaning.
Da klorhydrogen spaltes av ved dette skjer reaksjonen hensiktsmessig i nærvær av en base henholdsvis under anvendelse av et overskudd av aminet av formel, VI. Dessuten kan omsetningen gjennomfores på en for omsetningen av en forbindelse av formel VI med en forbindelse av formel VII analog måte. Since hydrogen chloride is split off by this, the reaction conveniently takes place in the presence of a base or using an excess of the amine of formula VI. Moreover, the reaction can be carried out in a manner analogous to the reaction of a compound of formula VI with a compound of formula VII.
Forbindelsene av formel XVI er kjente. Forbindelsene av formel Via, som delvis er nye, kan fremstilles på en for fremstilling av forbindelsene av formel VI analog måte. The compounds of formula XVI are known. The compounds of formula Via, which are partly new, can be prepared in a manner analogous to the preparation of the compounds of formula VI.
Reduksjonen av en karbonylgruppe henholdsvis en gruppe A til en forbindelse av formel XII eller XIII, kan gjennomfores på The reduction of a carbonyl group or a group A to a compound of formula XII or XIII can be carried out on
i og for seg kjent måte. in and of itself known manner.
Således kan et amid av formlene XII eller XIII, d.v.s. en forbindelse hvor karbonylgruppen er bundet direkte til nitrogenatomet, reduseres ved behandling med metallhydrider som f.eks. litiumaluminiumhydrid, diisobutylaluminiumhydrid eller med diboran. Dette skjer hensiktsmessig i et under reaksjonsbetingelsene inert, organisk opplosningsmiddel, som eter, f.eks. dietyleter, tetrahydrofuran eller i di- Thus, an amide of formulas XII or XIII, i.e. a compound where the carbonyl group is bound directly to the nitrogen atom is reduced by treatment with metal hydrides such as lithium aluminum hydride, diisobutylaluminum hydride or with diborane. This conveniently takes place in an organic solvent that is inert under the reaction conditions, such as ether, e.g. diethyl ether, tetrahydrofuran or in di-
glym og ved en temperatur mellom ca.O°C og reaksjonsblandingens tilbakelopstemperatur, fortrinnsvis ved ca. romtemperatur. glyme and at a temperature between about 0°C and the reflux temperature of the reaction mixture, preferably at about room temperature.
Reduksjonen av andre karbonylgrupper, d.v.s. slike som ikke er bundet direkte til nitrogenatomet, kan likeledes gjennomfores på i og for seg kjent måte. Særlig kan reduksjonen gjennomfores slik at den enten forer til tilsvarende hydroksymetylengruppe, som derpå kan ytterligere reduseres til metylengruppen, eller direkte til metylengruppen. The reduction of other carbonyl groups, i.e. those that are not bound directly to the nitrogen atom can likewise be carried out in a manner known per se. In particular, the reduction can be carried out so that it either leads to the corresponding hydroxymethylene group, which can then be further reduced to the methylene group, or directly to the methylene group.
Reduksjonen til hydroksymetylengruppen kan gjennomfores ved behandling med et komplekst metallhydrid, som et alkalimetallaluminiumhydrid eller et alkalimetallborhydrid. The reduction to the hydroxymethylene group can be carried out by treatment with a complex metal hydride, such as an alkali metal aluminum hydride or an alkali metal borohydride.
Reduksjonen ved hjelp av et alkalimetallaluminiumhydrid eller et alkalimetallborhydrid kan hensiktsmessig gjennomfores ved romtemperatur eller ved en temperatur under eller over romtemperatur og i et inert, organisk opplosningsmiddel. Som egnede opplosningsmidler ved reduksjonen med et alkalimetallaluminiumhydrid kan blant annet nevnes vannfri eter som dietyleter og tetrahydrøfuran og ved reduksjonen med et alkalimetallborhydrid, alkanoler med 1-4 karbonatomer, som metanol, etanol eller også dioksan. Som alkalimetallaluminiumhydrid anvendes fortrinnsvis litiumaluminiumhydrid og som alkalimetallborhydrid fortrinnsvis natriumborhydrid. The reduction using an alkali metal aluminum hydride or an alkali metal borohydride can conveniently be carried out at room temperature or at a temperature below or above room temperature and in an inert, organic solvent. Examples of suitable solvents for the reduction with an alkali metal aluminum hydride include anhydrous ether such as diethyl ether and tetrahydrofuran and for the reduction with an alkali metal borohydride, alkanols with 1-4 carbon atoms, such as methanol, ethanol or also dioxane. Lithium aluminum hydride is preferably used as alkali metal aluminum hydride and sodium borohydride is preferably used as alkali metal borohydride.
Den ytterligere reduksjon av en hydroksymetylengruppe til metylengruppen kan gjennomfores på i og for seg kjent måte,-særlig ved overforing til de tilsvarende sulfonsyreestere eller i halo-genider og reduksjon av disse med komplekse metallhydrider. The further reduction of a hydroxymethylene group to the methylene group can be carried out in a manner known per se, in particular by conversion to the corresponding sulphonic acid esters or to halides and reduction of these with complex metal hydrides.
Disse reduksjoner kan gjennomfores på en for for angående beskrevne reduksjon av karbonylgrupper analog måte. These reductions can be carried out in an analogous way to the described reduction of carbonyl groups.
Den direkte reduksjon av en karbonylgruppe til metylengruppen kan skje på i og for seg kjent måte, ved hjelp av en Wolff-Kishner reaksjon, d.v.s. ved omsetning av ketonet ved hjelp The direct reduction of a carbonyl group to the methylene group can take place in a manner known per se, by means of a Wolff-Kishner reaction, i.e. by reacting the ketone with the help of
av hydrazin til det tilsvarende hydrazon og spaltning av hydra-zonet under basiske betingelser. of hydrazine to the corresponding hydrazone and cleavage of the hydrazone under basic conditions.
De som utgangsmateriale anvendte forbindelse av formlene XII They used as starting material compounds of the formulas XII
og XIII er nye forbindelser. and XIII are new compounds.
Amider av formlen XII kan f.eks. fremstilles ved at man omsetter en syre av formlen Amides of the formula XII can e.g. is produced by reacting an acid of the formula
hvor R, Y, X og n har foran angitte betydninger, med et amin av formlen hvor R^ - R7, Z og m har foran angitte betydninger. Omsetningen kan hensiktsmessig skje i nærvær av et tertiært amin som trietylamin og en halogenkarboksylsyréester som klormaursyreisobutylester (blandet anhydridmetode) i et inert, organisk opplosningsmiddel, f.eks. tetrahydrofuran og ved en temperatur på ca. 0°C til ca. 30°C. Forbindelsene av formel XVII kan fremstilles på en for foranstående for fremstillingen av forbindelsene av formel XI be-skreven metode, analog måte ved å gå ut fra forbindelser av formlen where R, Y, X and n have the above meanings, with an amine of the formula where R 1 - R 7 , Z and m have the above meanings. The reaction can conveniently take place in the presence of a tertiary amine such as triethylamine and a halocarboxylic acid ester such as chloroformate isobutyl ester (mixed anhydride method) in an inert, organic solvent, e.g. tetrahydrofuran and at a temperature of approx. 0°C to approx. 30°C. The compounds of formula XVII can be prepared in a method described above for the preparation of the compounds of formula XI, analogously by starting from compounds of the formula
Forbindelsene av formlen XVIII horer til en kjent forbindelses-klasse. The compounds of the formula XVIII belong to a known compound class.
Ketonene av formel XII kan fremstilles på i og for seg kjent måte, f.eks. ved oksydasjon av de tilsvarende alkoholer. Oksydasjonen kan f.eks. skje med komplekset kromtrioksyd/pyridin i pyridin ved en temperatur på ca. -20°C til ca. romtemperatur, fortrinnsvis ved ca. 0°C. The ketones of formula XII can be prepared in a manner known per se, e.g. by oxidation of the corresponding alcohols. The oxidation can e.g. happen with the chromium trioxide/pyridine complex in pyridine at a temperature of approx. -20°C to approx. room temperature, preferably at approx. 0°C.
Fremstillingen av amidene av formel XIII kan skje på i og for seg kjent måte, f.eks. ved acylering av en forbindelse av formel I, hvor R^ betyr hydrogen. Acyleringen kan f.eks. skje med et halogenid av en lavere karboksylsyre i et tertiært amin, f.eks. pyridin, ved. en temperatur på ca. o°C til ca. 30°C, fortrinnsvis ved ca. romtemperatur. The production of the amides of formula XIII can take place in a manner known per se, e.g. by acylation of a compound of formula I, where R 1 means hydrogen. The acylation can e.g. happen with a halide of a lower carboxylic acid in a tertiary amine, e.g. pyridine, wood. a temperature of approx. o°C to approx. 30°C, preferably at approx. room temperature.
Overforingen av en forbindelse av formel I, hvor X er et svovelatom, til en forbindelse hvor X betyr SO eller SO2 kan skje ved oksydasjon i et egnet opplosningsmiddel, ved hjelp av per-syrer som pereddiksyre, perftalsyre, m-klorperbenzosyre The conversion of a compound of formula I, where X is a sulfur atom, to a compound where X means SO or SO2 can take place by oxidation in a suitable solvent, using peracids such as peracetic acid, perphthalic acid, m-chloroperbenzoic acid
Pereddiksyre kan f.eks. dannes in situ fra iseddik Peracetic acid can e.g. is formed in situ from glacial acetic acid
og hydrogensuperoksyd. and hydrogen peroxide.
Erholdte forbindelser av formel I, hvor R 4 betyr hydrogen, Obtained compounds of formula I, where R 4 means hydrogen,
kan alkyleres på i og for seg kjent måte, f.eks. ved hjelp av lavere alkylhalogenider. Den angjeldende forbindelse omsettes ved dette hensiktsmessig umiddelbart med alkylhalogenideb ved lav temperatur. can be alkylated in a manner known per se, e.g. using lower alkyl halides. The compound in question is suitably reacted immediately with alkyl halides at low temperature.
Overforingen av en lavere alkoksy- eller aryl-lavere alkoksy-gruppe til en hydroksygruppe kan gjennomfores på i og for seg kjent måte, f.eks. ved oppvarmning med en konsentrert halogen-hydrogensyre, særlig konstant kokende bromhydrogensyre. The transfer of a lower alkoxy or aryl-lower alkoxy group to a hydroxy group can be carried out in a manner known per se, e.g. by heating with a concentrated hydrohalic acid, especially constantly boiling hydrobromic acid.
Reduksjonen av en nitrogruppe til aminogruppen kan skje på i The reduction of a nitro group to the amino group can take place at i
og for seg kjente måte, på kjemisk eller katalytisk vei, f. eks. ved hjelp av tinn/saltsyre eller med hydrogen i nærvær av en edelmetallkatalysator. Hydrogeneringen gjennomfores fortrinnsvis i en alkanol, særlig etanol i nærvær av palladium/ kull eller platinoksyd under normalt trykk ved romtemperatur. and in a known manner, chemically or catalytically, e.g. using tin/hydrochloric acid or with hydrogen in the presence of a noble metal catalyst. The hydrogenation is preferably carried out in an alkanol, especially ethanol in the presence of palladium/charcoal or platinum oxide under normal pressure at room temperature.
Forsåpningen av en cyanogruppen kan gjennomfores på i og for seg kjent måte, ved hjelp av en syre eller en base. The saponification of a cyano group can be carried out in a manner known per se, using an acid or a base.
Forestringen henholdsvis amideringen av en karboksylgruppe kan gjennomfores på i og for seg kjent måte, f.eks. ved behandling med en tilsvarende alkohol henholdsvis et tilsvarende amin. The esterification or amidation of a carboxyl group can be carried out in a manner known per se, e.g. by treatment with a corresponding alcohol or a corresponding amine.
En tilstedeværende aminogruppe: kan som nevnt foran alkyleres eller også ved behandling med et syrehalogenid eller syreanhydrid acyleres på i og for seg kjent måte. A present amino group: can, as mentioned above, be alkylated or, by treatment with an acid halide or acid anhydride, acylated in a manner known per se.
Foretringen, såvel som forestringen av en tilstedeværende hydroksygruppe kan skje på i og for seg kjent måte, f.eks. ved omsetning med et tilsvarende halogenid, henholdsvis med et tilsvarende syrehalogenid eller et syreanhydrid. The esterification, as well as the esterification of a hydroxy group present, can take place in a manner known per se, e.g. by reaction with a corresponding halide, respectively with a corresponding acid halide or an acid anhydride.
Reduksjonen av en karboksylgruppe kan gjennomfores på i og for seg kjent måte, f.eks. ved hjelp av diboran eller litiumalu-rainiumhydrid i et inert, organisk opplosningsmiddel. The reduction of a carboxyl group can be carried out in a manner known per se, e.g. using diborane or lithium aluminum hydride in an inert organic solvent.
Oksydasjonen av en alkyltiogruppe kan skje på i og for seg kjent måte, f.eks. ved hjelp av hydrogensuperoksyd. The oxidation of an alkylthio group can take place in a manner known per se, e.g. using hydrogen peroxide.
Forbindelsene av formel I kan overfores til syreaddisjonssalter, f.eks. ved behandling med en anorganisk syre, som en halogen-hydrogensyre, f.eks. klorhydrogen- eller bromhydrogensyre, svovelsyre, fosforsyre eller med en organisk syre som oksalsyre, vinsyre, sitronsyre, metansulfonsyre. The compounds of formula I can be converted into acid addition salts, e.g. by treatment with an inorganic acid, such as a halogen-hydrogen acid, e.g. hydrochloric or hydrobromic acid, sulfuric acid, phosphoric acid or with an organic acid such as oxalic acid, tartaric acid, citric acid, methanesulfonic acid.
Av syreaddisjonssaltene av forbindelsene av formel I er de far-masøytisk anvendelige foretrukne. Oppnås i lopet av fremgangsmåten etter oppfinnelsen et syreaddisjonssalt av en forbindelse av formel I, så kan et slikt salt overfores på kjent måte, f.eks. ved behandling med alkali, til den frie base og denne kan, hvis onsket, overfores til et syreaddisjonssalt. Of the acid addition salts of the compounds of formula I, the pharmaceutically usable ones are preferred. If an acid addition salt of a compound of formula I is obtained in the course of the method according to the invention, then such a salt can be transferred in a known manner, e.g. by treatment with alkali, to the free base and this can, if desired, be transferred to an acid addition salt.
De forbindelser av formel I, som inneholder et asymmetrisk karbonatom,kan foreligge i racemisk eller i optisk aktiv form og både de racemiske som de optiske aktive former er gjenstand for foreliggende oppfinnelse. Et racemat. kan, hvis onsket, spaltes o'pp<r>på i og for seg kjent måte til de optiske antipo-der, f.eks. ved fraksjonert krystallisasjon av de tilsvarende salter med en optisk aktiv syre. The compounds of formula I, which contain an asymmetric carbon atom, can exist in racemic or optically active form and both the racemic and the optically active forms are the subject of the present invention. A race food. can, if desired, be split o'pp<r>in a manner known per se to the optical antipodes, e.g. by fractional crystallization of the corresponding salts with an optically active acid.
Forbindelsene av formel I, såvel som deres syreaddisjonssalter er i besiddelse av verdifulle coronardilaterende egenskaper og kan således bl.a. finne anvendelse for behandling av angina pectoris. The compounds of formula I, as well as their acid addition salts, possess valuable coronary dilating properties and can thus i.a. find application for the treatment of angina pectoris.
Den coronardilaterende virkning kan måles etter følgende metode: The coronary dilating effect can be measured according to the following method:
For undersøkelsen anvendes bastardhunder med vekt mellom 20 For the investigation, bastard dogs weighing between 20 and 20 kg are used
og 38 kg. Forsøksdyrene narkotiseres med ca. 30 mg/kg i.v. pentobarbital og narkosen opprettholdes med kloralose-uretan. Kunstig ånding opprettholdes for dyrene med romluft. Etter åpning av thorax frilegges hjertet og om Ramus circumflexus and 38 kg. The experimental animals are drugged with approx. 30 mg/kg i.v. pentobarbital and anesthesia is maintained with chloralose-urethane. Artificial respiration is maintained for the animals with room air. After opening the thorax, the heart and the Ramus circumflexus are exposed
i den venstre coronararterie legges en på forhånd avmålt Flow-probe av et elektromagnetisk flow-meter for måling av den gjennomstrommende blodmengde. Det arterielle blodtrykk måles over et kateter i arteria femoralis med trykk-transducer. Videre påsys på overflaten av den venstre ventrikkel en kalibrert utvidelsesmåleremse for direkte måling av myokardial kon-traksjonskraft. Pulsbolgen for blodtrykket utløser en tachograf for måling av hjertefrekvensen. Vannopploselige preparater opp-løses i isotonisk koksaltopplosning, vannuopploselige i propylenglykol, adminsitreres intravenøst eller som suspensjon i gummi arabicum intraduodenalt. Den maksimale virkning av en substans beregnes etter hver dosering i prosent av utgangsverdien og gjengis grafisk. Ved måling av coronargjennomblodningen tas det særlig hensyn til virkningsvarigheten. In the left coronary artery, a pre-measured Flow probe of an electromagnetic flow meter is placed to measure the amount of blood flowing through. The arterial blood pressure is measured over a catheter in the femoral artery with a pressure transducer. Furthermore, a calibrated dilatation measuring strip is provided on the surface of the left ventricle for direct measurement of myocardial contraction force. The pulse wave for the blood pressure triggers a tachograph for measuring the heart rate. Water-soluble preparations are dissolved in isotonic sodium chloride solution, water-insoluble in propylene glycol, administered intravenously or as a suspension in gum arabic intraduodenal. The maximum effect of a substance is calculated after each dosage as a percentage of the initial value and displayed graphically. When measuring coronary blood flow, special consideration is given to the duration of action.
I den følgende tabell er de oppnådde resultater sammenstillt, idet n betyr antallet anvendte dyr. In the following table, the results obtained are compiled, where n means the number of animals used.
For undersøkelsene anvendte man bastardhunder med vekt mellom For the investigations, bastard dogs with weights in between were used
20 og 38 kg. Forsøksdyrene ble narkotisert med ca. 30 mg/kg i.v. pentobarbital og narkosen ble holdt ved like med kloralose-uretan. Dyrene fikk kunstig åndedrett med romluft. Etter åpning av thorax ble hjertet blottlagt og rundt Ramus circumflexus av venstre coronararterie lagt en forut kalibrert strøm-ningsprøve av en elektromagnetisk strømningsmåler for måling av den gjennomstrømmende blodmengde. Vannløselige preparater ble intravenøst applisert i isotonisk koksaltløsning, vannuløse-lige løst i propylenglykol. Den maksimale virkning av en substans ble beregnet som følge av hver dosering i prosent av begynnelsesverdien og grafisk fremstilt. 20 and 38 kg. The experimental animals were drugged with approx. 30 mg/kg i.v. pentobarbital and the anesthesia were maintained with chloralose-urethane. The animals received artificial respiration with room air. After opening the thorax, the heart was exposed and around the Ramus circumflexus of the left coronary artery a pre-calibrated flow sample of an electromagnetic flow meter was placed to measure the amount of blood flowing through. Water-soluble preparations were administered intravenously in isotonic saline solution, water-soluble ones dissolved in propylene glycol. The maximum effect of a substance was calculated as a result of each dosage as a percentage of the initial value and presented graphically.
I den følgende tabell I er angitt de erholdte resultater for The following table I shows the results obtained for
3 forbindelser, idet n betyr antallet av anvendte dyr. Som det fremgår av tabellen oppnår man ved økning av dosen et virknings-maksimum,som ved ytterligere økning av dosen igjen vil synke. 3 compounds, where n means the number of animals used. As can be seen from the table, when the dose is increased, a maximum effect is achieved, which will decrease again when the dose is increased further.
I den følgende tabell II er sammenfattet disse virkningsmaksima for et representativt antall forbindelser ifølge foreliggende ansøkning. The following table II summarizes these action maxima for a representative number of compounds according to the present application.
Fremgangsmåteproduktene og deres farmasøytisk anvendelige syreaddisjonssalter kan finne anvendelse som legemidler i form av farmasøytiske preparater, som inneholder disse pro-dukter i blanding med et for den enterale eller parenterale administrasjon egnet farmasøytisk, organisk eller uorganisk inert bæremateriale, som f.eks. vann, gelatin, gummi arabicum, melkesukker, stivelse, magnesiumstearat, talkum, vegetabilske oljer, polyalkylenglykol, vaseliner. De farmasøytiske preparater kan foreligge i fast form, f.eks. som tabletter, dragéer, kapsler eller i flytende form, f.eks. i oppløsninger, suspensjoner eller emulsjoner. Eventuelt er de sterilisert øg henh. eller inneholder hjelpestoffer, som konserverings-, stabiliserings-, fuktnings- eller emulgeringsmidler, salter til forandring av det osmotiske trykk eller puffer. The process products and their pharmaceutically usable acid addition salts can find use as drugs in the form of pharmaceutical preparations, which contain these products in admixture with a pharmaceutical, organic or inorganic inert carrier material suitable for enteral or parenteral administration, such as e.g. water, gelatin, gum arabic, milk sugar, starch, magnesium stearate, talc, vegetable oils, polyalkylene glycol, petroleum jelly. The pharmaceutical preparations can be in solid form, e.g. as tablets, dragées, capsules or in liquid form, e.g. in solutions, suspensions or emulsions. If necessary, they are also sterilized according to or contains auxiliary substances, such as preservatives, stabilisers, wetting or emulsifying agents, salts to change the osmotic pressure or buffers.
Den daglige dose ved oral administrasjon ligger mellom ca. 10-200 mg, ved intravenos administrasjon mellom ca. 1-20 mg. The daily dose for oral administration is between approx. 10-200 mg, by intravenous administration between approx. 1-20 mg.
De angitte doseringer er imidlertid bare å forstå som eksemp-ler og kan endres alt etter vanskeligheten av det sykdomstil-felle som skal behandles og etter den behandlende leges ut-måling. However, the stated dosages are only to be understood as examples and can be changed according to the difficulty of the disease to be treated and according to the treating doctor's assessment.
EKSEMPEL 1 EXAMPLE 1
74,7 g 3,4-dimetoksybenzaldehyd loses i 1250 ml kloroform og tilsettes 50 ml 1,3-propanditiol og avkjøles under omrøring ved 0°C. 20 ml bortrifluorideterat tilsettes til dette og reaksjons-blandingen står til henstand i 18 timer i kjoleskap. Deretter vaskes det tre ganger suksessivt med 500 ml av en 7%'ig KOK- 74.7 g of 3,4-dimethoxybenzaldehyde is dissolved in 1250 ml of chloroform and 50 ml of 1,3-propanedithiol is added and cooled with stirring at 0°C. 20 ml of boron trifluoride etherate is added to this and the reaction mixture is allowed to stand for 18 hours in a refrigerator. It is then washed three times successively with 500 ml of a 7% KOK-
losning og 500 ml av en 10%'ig NaCl-løsning. De organiske ekstraktene forenes, tørkes med magnesiumsulfat og inndampes. solution and 500 ml of a 10% NaCl solution. The organic extracts are combined, dried with magnesium sulfate and evaporated.
Resten omkrystalliseres to ganger med eter. Man erholder 102,6 The residue is recrystallized twice with ether. You get 102.6
g 2-(3,4-dimetoksyfenyl)-m-ditian med et smeltepunkt på 99 - g 2-(3,4-dimethoxyphenyl)-m-dithiane with a melting point of 99 -
101°C. 101°C.
På analog måte kan de følgende ditianer fremstilles: 2-(o-metoksyfenyl)-m-ditian: smeltepunkt 126 - 127°C (fra CH2C12/i sopropyleter) In an analogous way, the following dithianes can be prepared: 2-(o-methoxyphenyl)-m-dithiane: melting point 126 - 127°C (from CH2C12/isopropyl ether)
2-fenyl-m-ditian: smeltepunkt 72 - 73°C (fra CH2C12/isopropyl- 2-phenyl-m-dithiane: melting point 72 - 73°C (from CH2C12/isopropyl-
eter ) ether )
2-(p-klorfenyl)-m-ditian: smeltepunkt 87 - 88°C (fra CH2C12/ i sopropyleter) 2-(p-Chlorophenyl)-m-dithiane: melting point 87 - 88°C (from CH2C12/ in isopropyl ether)
2-(m-metoksyfenyl)-m-ditian: smeltepunkt 62 - 63°C (fra isopropyleter) 2-(m-Methoxyphenyl)-m-dithiane: melting point 62 - 63°C (from isopropyl ether)
2- (3,4-,5-trimetoksyfenyl)rm-ditian: smeltepunkt 88 - 89°C (fra CH2C12/isopropyleter) 2-(3,4-,5-trimethoxyphenyl)rm-dithiane: melting point 88 - 89°C (from CH2C12/isopropyl ether)
2-(m-klorfenyl)-m-ditian: smeltepunkt 63 - 64°C (fra cykloheksan) 2-(3,5-dimetoksyfenyl)-m-ditian: smeltepunkt 90 - 91°C (fra cykloheksan) 2-(m-chlorophenyl)-m-dithiane: melting point 63 - 64°C (from cyclohexane) 2-(3,5-dimethoxyphenyl)-m-dithiane: melting point 90 - 91°C (from cyclohexane)
p-(m-ditian-2-yl)-N,N-dimetylanilin: smeltepunkt 118 - 119°C p-(m-dithian-2-yl)-N,N-dimethylaniline: melting point 118 - 119°C
(fra cykloheksan) (from cyclohexane)
2-(m-nitrofenyl)-m-ditian: smeltepunkt 117 - 118°C (fra CH2Cl2/metanol) 2-(m-nitrophenyl)-m-dithiane: melting point 117 - 118°C (from CH2Cl2/methanol)
2-(3,4-metylendioksyfenyl)-m-ditian: smeltepunkt 86 - 87°C 2-(3,4-methylenedioxyphenyl)-m-dithiane: melting point 86 - 87°C
(fra cykloheksan) (from cyclohexane)
2-p-tolyl-m-ditian: smeltepunkt 89 - 90°C (fra eter/heksan) 2-(m-bromfenyl)-m-ditian: smeltepunkt 78 - 79°C (fra cykloheksan) 2-(2-naftyl)-m-ditian: smeltepunkt 110 - 111°C (fra cyklo-heksan) 2-(2,4,5-trimetoksyfenyl)-m-ditian: smeltepunkt 156 - 157°C 2-p-tolyl-m-dithiane: melting point 89 - 90°C (from ether/hexane) 2-(m-bromophenyl)-m-dithiane: melting point 78 - 79°C (from cyclohexane) 2-(2-naphthyl )-m-dithiane: melting point 110 - 111°C (from cyclo-hexane) 2-(2,4,5-trimethoxyphenyl)-m-dithiane: melting point 156 - 157°C
(fra CH2Cl2/metanol) (from CH2Cl2/methanol)
2-(p-fluorfenyl)-m-ditian: smeltepunkt 105 - 106°C (fra cyklo-heksan) 2-(p-fluorophenyl)-m-dithiane: melting point 105 - 106°C (from cyclohexane)
2- (4-bifenylyl)-m-ditian: smeltepunkt 148 - 151°C (fra tetrahydrofuran/cykloheksan) 2-(4-biphenylyl)-m-dithiane: melting point 148 - 151°C (from tetrahydrofuran/cyclohexane)
2-(a,a,a-trifluor-p-tolyl)-m-ditian: smeltepunkt 103 - 104°C 2-(α,α,α-trifluoro-p-tolyl)-m-dithiane: melting point 103 - 104°C
(fra cykloheksan) (from cyclohexane)
2-(1-naftyl)-m-ditian: smeltepunkt 147 - 148°C (fra cykloheksan) 2-(3-benzyloksy-4-metoksyfenyl)-m-ditian: smeltepunkt 168 - 170°C 2-(1-Naphthyl)-m-dithiane: melting point 147 - 148°C (from cyclohexane) 2-(3-benzyloxy-4-methoxyphenyl)-m-dithiane: melting point 168 - 170°C
(fra cykloheksan) (from cyclohexane)
2-(4-benzyloksy-3-metoksyfenyl)-m-ditian: smeltepunkt 118 - 119°C 2-(4-benzyloxy-3-methoxyphenyl)-m-dithiane: melting point 118 - 119°C
'fra cykloheksan) 'from cyclohexane)
2-(2-tienyl)-m-ditian: smeltepunkt 74 - 75°C (fra cykloheksan) 2- (a , a , cc-trif luor-m-tolyl) -m-ditian: smeltepunkt 69 - 71°C 2-(2-thienyl)-m-dithiane: melting point 74 - 75°C (from cyclohexane) 2-(a , a ,cc-trifluoro-m-tolyl) -m-dithiane: melting point 69 - 71°C
(fra heptan) (from heptane)
2-(p-isopropylfenyl)-m-ditian': smeltepunkt 58 - 59°C (fra heksan) 2-(3,4-xylyl)-m-ditian: fp. 74 - 75°C (petroleter) 2-(p-isopropylphenyl)-m-dithiane': mp 58 - 59°C (from hexane) 2-(3,4-xylyl)-m-dithiane: m.p. 74 - 75°C (petroleum ether)
2- (3-butoksy-4-metoksyfenyl)-m-ditian 2-(3-butoxy-4-methoxyphenyl)-m-dithiane
2-(4-etoksy-3-metoksyfenyl)-m-ditian: fp. 88 - 90°C (fra metylen- 2-(4-ethoxy-3-methoxyphenyl)-m-dithiane: m.p. 88 - 90°C (from methylene-
klorid + isopropyleter) chloride + isopropyl ether)
m-(m-ditian-2-yl)-benzonitril: fp. 84 - 86°C (fra isopropyleter) 6-m-ditian-2-yl-l,4-benzodioksan: fp. 140 - 142°C (fra metylen- m-(m-dithian-2-yl)-benzonitrile: m.p. 84 - 86°C (from isopropyl ether) 6-m-dithian-2-yl-1,4-benzodioxane: m.p. 140 - 142°C (from methylene-
klorid + isopropyleter) chloride + isopropyl ether)
2-(4-metoksy-m-toiyl)-m-ditian: fp. 75 77°C (fra cykloheksan). 2-(4-Methoxy-m-thioyl)-m-dithiane: m.p. 75 77°C (from cyclohexane).
EKSEMPEL. 2 EXAMPLE. 2
60 g 2-(3,4-dimetoksyfenyl)-m-ditian (fremstilt ifølge eksempel 60 g of 2-(3,4-dimethoxyphenyl)-m-dithiane (prepared according to example
1) loses i 470 ml iseddik og tilsettes ved romtemperatur 1) dissolved in 470 ml of glacial acetic acid and added at room temperature
-'V:' rv'2-35 ml »3;0%' i'g H2b2- ,./hypcve'd~:.-tohp;5r^^réh'' - til .;opp3L;osningen* stfigéiS "'*..•" • ..';''' til ca. 40°C. Oppløsningen lar man stå natten over ved rom- -'V:' rv'2-35 ml »3;0%' i'g H2b2- ,./hypcve'd~:.-tohp;5r^^réh'' - to .;opp3L;osningen* stfigéiS " '*..•" • ..';''' to approx. 40°C. The solution is allowed to stand overnight at room temperature.
temperatur. Deretter oppvarmes det i 2 timer til 100°C. Etter avkjøling til romtemperatur nutsjes det krystallinske bunn- temperature. It is then heated for 2 hours to 100°C. After cooling to room temperature, the crystalline base is
fallet fra, vaskes med noe iseddik, tørkes i vakuum ved 60°C fall off, wash with some glacial acetic acid, dry in vacuum at 60°C
natten over og omkrystalliseres deretter i acetonitril. Man erholder 57,1 g 2-(3,4-dimetoksyfenyl)-m-ditian-1,1,3,3- overnight and then recrystallized from acetonitrile. 57.1 g of 2-(3,4-dimethoxyphenyl)-m-dithiane-1,1,3,3-
tetraoksyd med et smeltepunkt på 243 - 245°C. tetraoxide with a melting point of 243 - 245°C.
Analogt det som er beskrevet foran kan de følgende ditiano- Analogously to what is described above, the following ditiano-
tetraoksyder fremstilles: tetraoxides are produced:
2-(m-bromfenyl)-m-ditian-1,1,3,4-tetraoksyd: smeltepunkt 230 - 2-(m-bromophenyl)-m-dithiane-1,1,3,4-tetraoxide: melting point 230 -
231 C (fra acetonitril) 231 C (from acetonitrile)
2-(p-fluorfenyl)-m-ditian-1,1,3.3-tetraoksyd: smeltepunkt 283 - 2-(p-Fluorophenyl)-m-dithiane-1,1,3,3-tetraoxide: melting point 283 -
284 C (fra acetonitril 284 C (from acetonitrile
2-(m-nitrofenyl)-m-ditian-1.1,3.3-tetraoksyd: smeltepunkt 256 - 2-(m-nitrophenyl)-m-dithiane-1.1,3.3-tetraoxide: melting point 256 -
257 c (fra acetonitril) 257 c (from acetonitrile)
2-(3,4 ,5-tr^metoksyfenyl)-m-ditian-1,1,3,3-tetraoksyd: smelte- 2-(3,4,5-trimethoxyphenyl)-m-dithiane-1,1,3,3-tetraoxide: melting
punkt >310 C (fra acetonitril) point >310 C (from acetonitrile)
2-(2-naftyl)-m-ditian-1,1,3,3-tetraoksyd: smeltepunkt 277 - 278°C 2-(2-naphthyl)-m-dithiane-1,1,3,3-tetraoxide: melting point 277 - 278°C
(fra aceton/acetonitril) (from acetone/acetonitrile)
2-p-tolyl-m-ditian-l,1,3,3-tetraoksyd: smeltepunkt 284 - 285°C 2-p-tolyl-m-dithiane-1,1,3,3-tetraoxide: melting point 284 - 285°C
(fra acetonitril) (from acetonitrile)
2-(4-benzyloksy-3-metgksyfenyl)-m-ditian-1,1,3,3-tetraoksyd: 2-(4-Benzyloxy-3-methylxyphenyl)-m-dithiane-1,1,3,3-tetraoxide:
smeltepunkt 220 - 223 C (fra ace'ton/acetoni tril) melting point 220 - 223 C (from acetone/aceton tril)
2- (3,4-dimetoksyfenyl)-1,3-ditiolan-l,1,3,3-tetraoksyd: smelte- 2-(3,4-dimethoxyphenyl)-1,3-dithiolane-1,1,3,3-tetraoxide: melt-
punkt 194 - 196 C (fra aceton/acetonitril) point 194 - 196 C (from acetone/acetonitrile)
2- (3,4-metylendioksyfenyl)-m-ditian-1,1,3,3-tetraoksyd: smelte- 2-(3,4-methylenedioxyphenyl)-m-dithiane-1,1,3,3-tetraoxide: melting
punkt >300 C (fra aceton/acetonitril) point >300 C (from acetone/acetonitrile)
2-(2<1->tienyl)-m-ditian-1,1,3,3-tetraoksyd: smeltepunkt >300°C 2-(2<1->thienyl)-m-dithiane-1,1,3,3-tetraoxide: melting point >300°C
(fra aceton/acetonitril) (from acetone/acetonitrile)
2- (3,4-diklorfenyl)-m-ditian-1,1,3,3-tetraoksyd: smeltepunkt 254 - 255 C (fra iseddik-vann) 2-(3,4-dichlorophenyl)-m-dithiane-1,1,3,3-tetraoxide: melting point 254 - 255 C (from glacial acetic acid-water)
2- (a,a,a-triflupr-m-tolyl)-m-ditian-1,1,3,3-tetraoksyd: smelte- 2-(α,α,α-triflupr-m-tolyl)-m-dithiane-1,1,3,3-tetraoxide: melt-
punkt 239 - 242 C (fra iseddik-vann) point 239 - 242 C (from glacial acetic acid-water)
2- (p-isopropylfenyl)-m-ditian-1,1,3,3-tetraoksyd: smeltepunkt 204 - 205 C (fra acetonitril-etanol) 2-(p-isopropylphenyl)-m-dithiane-1,1,3,3-tetraoxide: melting point 204 - 205 C (from acetonitrile-ethanol)
2- (3^,4-xylyl) -m-ditian-1,1,3 ,3-tetraoksyd: smeltepunkt 268 - 2-(3^,4-xylyl)-m-dithiane-1,1,3,3-tetraoxide: melting point 268 -
269 C (fra acetonitril + metanol) 269 C (from acetonitrile + methanol)
2- (3-butoksy-4-metoksyferiyl)-m-ditian-1,1,3,3-tetraoksyd: 2-(3-Butoxy-4-methoxyphenyl)-m-dithiane-1,1,3,3-tetraoxide:
smeltepunkt 225 - 227 C (fra iseddik-vann) melting point 225 - 227 C (from glacial acetic acid-water)
2- (4-etoksy-3-metoksyf enyl) -m-ditian-1,1 ,.3} 3-tetraoksyd:' smelte-• . punkt,''.242 2'44 C (f ra Jaceton-acetoni tril.)'i : . • '. '" .' ' m-(m-ditian-2'-vi)-benzonitril-1',1',3',31-tetraoksyd:.smelte- 2-(4-ethoxy-3-methoxy enyl)-m-dithian-1,1,.3} 3-tetraoxide:' melt-• . point,''.242 2'44 C (from Jaceton-acetoni tril.)'i : . • '. '" .' 'm-(m-dithian-2'-vi)-benzonitrile-1',1',3',31-tetraoxide:.melt-
punkt 259 - 260 C (fra iseddik-vann) point 259 - 260 C (from glacial acetic acid-water)
6-m-ditian-2'-y^-1,4-benzodioksan-l<1>,1',3',3'-tetraoksyd: 6-m-dithian-2'-y^-1,4-benzodioxane-1<1>,1',3',3'-tetraoxide:
smeltepunkt 232 C spaltning, (fra iseddik-vann) melting point 232 C decomposition, (from glacial acetic acid-water)
2(4-metoksy-m-tolyl)-m-ditian-1',1',3',3'-tetraoksyd: smelte- 2(4-methoxy-m-tolyl)-m-dithiane-1',1',3',3'-tetraoxide: melting
punkt 225 - 227 C (fra iseddik-vann). point 225 - 227 C (from glacial acetic acid-water).
EKSEMPEL 3 EXAMPLE 3
I en sulfureringskolbe avkjoles under argon-gassing 19,2 g 2-(3,4-dimetoksyfenyl)-m-ditian (fremstilt ifolge eksempel 1) og 200 ml tetrahydrofuran til -60°C og tilsettes langsomt 33 ml butyllitium i heksan. Deretter rbres blandingen 2 timer ved In a sulfurization flask, under argon gassing, 19.2 g of 2-(3,4-dimethoxyphenyl)-m-dithane (prepared according to example 1) and 200 ml of tetrahydrofuran are cooled to -60°C and 33 ml of butyllithium in hexane are slowly added. The mixture is then stirred for 2 hours
-20°C. En opplosning av 18 g N-(3-klorpropyl)-3,4-dimetoksy-N-metyl-fenetylamin i 200 ml tetrahydrofuran tildryppes dette -20°C. A solution of 18 g of N-(3-chloropropyl)-3,4-dimethoxy-N-methyl-phenethylamine in 200 ml of tetrahydrofuran is added dropwise to this
i lbpet av 15 minutter ved -70°C. Man lar så dette stå til henstand 18 timer ved -20°C i dypfryser og 3 timer ved rom- in increments of 15 minutes at -70°C. This is then allowed to stand for 18 hours at -20°C in a deep freezer and 3 hours at room-
temperatur. Reaksjonsopplosningen helles så på vann og eks- temperature. The reaction solution is then poured onto water and ex-
traheres tre ganger med eter. De eterholdige ekstraktene eks- triturated three times with ether. The ethereal extracts ex-
traheres tre .ganger med 250 ml 1 N KC1. De sure ekstraktene tilsettes 3 N natriumhydroksyd inntil pH >12 og den ut-skilte oljen ekstraheres med eter. De organiske ekstraktene torkes med magnesiumsulfat og inndampes. Den således erholdte oljen (30 g) loses i eddikester og tilsettes eterholdig HBr. Det utfelte bunnfallet omkrystalliseres i etanol. Man erholder N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin-hydrobromid med et smeltepunkt på 170 - 172°C. is triturated three times with 250 ml of 1 N KC1. 3 N sodium hydroxide is added to the acidic extracts until pH >12 and the separated oil is extracted with ether. The organic extracts are dried with magnesium sulfate and evaporated. The oil thus obtained (30 g) is dissolved in vinegar and ethereal HBr is added. The precipitate precipitated is recrystallized in ethanol. N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamine hydrobromide with a melting point of 170 - 172°C is obtained.
Analyse for C2gH37N04S2-HBrAnalysis for C2gH37N04S2-HBr
Det som utgangsmateriale anvendte N-(3-klorpropyl)-3,4-dimetoksy-N-metyl-fenetylamin kan fremstilles som folger: 292,5 g N-metylhomoveratrylamin loses i 1000 ml dimetylformamid og tilsettes 415 g vannfritt kaliumkarbonat. Blandingen rores ved 5°C, tilsettes 237 g 1,3 bromklorpropan i 500 ml dimetylformamid, rores ytterligere 4 timer ved romtemperatur og helles så i 6 Ilter vann. Den oljen som utskilles ekstra- ■ heres tre ganger med hver gang 2 liter eter. De organiske ekstraktene torkes med magnesiumsulfat og inndampes i vakuum. Den gjenværende oljen destilleres med en kvikksolvdiffusjons-pumpe ved 0,005 mmHg mellom 69 og 70°C. Man erholder 206,7 The N-(3-chloropropyl)-3,4-dimethoxy-N-methyl-phenethylamine used as starting material can be prepared as follows: 292.5 g of N-methylhomoveratrylamine are dissolved in 1000 ml of dimethylformamide and 415 g of anhydrous potassium carbonate are added. The mixture is stirred at 5°C, 237 g of 1.3 bromochloropropane in 500 ml of dimethylformamide are added, stirred for a further 4 hours at room temperature and then poured into 6 liters of water. The oil that is secreted extra- ■ here three times with each time 2 liters of ether. The organic extracts are dried with magnesium sulphate and evaporated in vacuo. The remaining oil is distilled with a mercury vapor diffusion pump at 0.005 mmHg between 69 and 70°C. You get 206.7
g N-(3-klorpropyl)-3,4-dimetoksy-N-metyl-fenetylamin: kokepunkt 69 - 70°C/0,005 mmHg. g N-(3-chloropropyl)-3,4-dimethoxy-N-methyl-phenethylamine: boiling point 69 - 70°C/0.005 mmHg.
Analogt det foran beskrevne kan folgende forbindelser fremstilles: N-(3,4-dimetoksyfenetyl)-2-(m-metoksyfenyl)-N-mgtyl-m-ditian-2-propylamin-hydroklorid: smeltepunkt 113 - 115 C (av aceton) N-(3,4-dimetoksyfenetyl-2- (3,4,5-trimetoksyfenyl)-N-metyJ-m-ditian-2-propylamin-hydroklorid: smeltepunkt 14 7 - 150 C Analogously to what was described above, the following compounds can be prepared: N-(3,4-dimethoxyphenethyl)-2-(m-methoxyphenyl)-N-mgtyl-m-dithian-2-propylamine hydrochloride: melting point 113 - 115 C (from acetone) N-(3,4-dimethoxyphenethyl-2-(3,4,5-trimethoxyphenyl)-N-methyl-m-dithian-2-propylamine hydrochloride: melting point 14 7 - 150 C
(av aceton) (of acetone)
N-(3,4-dimetoksyfenetyl)-2-(p-metoksyfenyl)-N-metyl-m-ditian-2-propylamin-hydroklorid: smeltepunkt 160 - 161 C (av aceton) N-(3,4-dimetoksyfenetyl)-2-(o-metoksyfenyl)-N-metyl-m-ditian-2-propylamin-hydroklorid: smeltepunkt 151 - 152°C (av aceton) 2- (p-klorfenyl)-N-(3,4-dimetoksyfenetyl)-N-metyl-m-ditian-2-propylamin-hydroklorid: smeltepunkt 137 - 139 C (av aceton) N- (3 ,4-dimetoksyfenetyl)-N-metyl-2-fenyl-m-ditian-2-propylamin-hydroklorid: smeltepunkt 170 - 172 C (av aceton) N- (3,4-dimetoksyfenetyl)-N-metyl-2-(3,4-metylendioksyfegyl)-m-ditian-2-propylamin-hydroklorid: smeltepunkt: 139 - 141 C N-(3,4-dimethoxyphenethyl)-2-(p-methoxyphenyl)-N-methyl-m-dithiane-2-propylamine hydrochloride: melting point 160 - 161 C (of acetone) N-(3,4-dimethoxyphenethyl) -2-(o-methoxyphenyl)-N-methyl-m-dithian-2-propylamine hydrochloride: melting point 151 - 152°C (of acetone) 2-(p-chlorophenyl)-N-(3,4-dimethoxyphenethyl) -N-methyl-m-dithian-2-propylamine hydrochloride: melting point 137 - 139 C (of acetone) N-(3,4-dimethoxyphenethyl)-N-methyl-2-phenyl-m-dithian-2-propylamine- hydrochloride: melting point 170 - 172 C (of acetone) N-(3,4-dimethoxyphenethyl)-N-methyl-2-(3,4-methylenedioxyphegyl)-m-dithiane-2-propylamine hydrochloride: melting point: 139 - 141 C
(av aceton) (of acetone)
N- (3,4-dimetoksyfenetyl)-N-metyl-2-(p-tolyl)-m-ditian-2-propylamin-hydroklorid: smeltepunkt 139 - 141 C (av aceton) 2- (m-klorfenyl)-N-(3,4-dimetoksyfenetyl)-N-me^yl-m-ditian-2-propylamin-hydroklorid: smeltepunkt 108 - 110 C (av aceton) N- (3,4-dimetoksyfenetyl)-2-(3,5-dimetoksyfenyl)-N-metyl-m-diti an-2-propylamin-oksalat (1:1): smeltepunkt 155 - 156 C N-(3,4-dimethoxyphenethyl)-N-methyl-2-(p-tolyl)-m-dithian-2-propylamine hydrochloride: melting point 139 - 141 C (from acetone) 2-(m-chlorophenyl)-N -(3,4-dimethoxyphenethyl)-N-methyl-m-dithian-2-propylamine hydrochloride: melting point 108 - 110 C (from acetone) N-(3,4-dimethoxyphenethyl)-2-(3,5 -dimethoxyphenyl)-N-methyl-m-dithiane-2-propylamine-oxalate (1:1): melting point 155 - 156 C
(av aceton) (of acetone)
N- (3,4-dimetoksyfenetyl)-2-(p-dimetylaminofenyl)-N-met^l-m-ditian-2-propylamin-hydroklorid: smeltepunkt 183 - 184 C N-(3,4-dimethoxyphenethyl)-2-(p-dimethylaminophenyl)-N-methyl-m-dithian-2-propylamine hydrochloride: melting point 183 - 184 C
(i aceton) (in acetone)
N- (3,4-dimetoksyfenetyl)-N-metyl-2-(2-naftyl)-m-ditian-2-propylamin-hydroklorid: smeltepunkt 195 - 196 C (av aceton) N- (3,4-dimetoksyfenetyl)-N-metyl-2-(2,4,5-trimetoksyfeny^)-m-ditian-2-propylamin-hydroklorid: smeltepunkt 156 - 158 C N-(3,4-dimethoxyphenethyl)-N-methyl-2-(2-naphthyl)-m-dithian-2-propylamine hydrochloride: melting point 195 - 196 C (of acetone) N-(3,4-dimethoxyphenethyl) -N-methyl-2-(2,4,5-trimethoxyphenyl)-m-dithian-2-propylamine hydrochloride: melting point 156 - 158 C
(av aceton) (of acetone)
N- (3,4-dimetoksyfenetyl)-2-(p-fluorfenyl)-N-mety^l-m-ditian-2-propylamin-hydroklorid: smeltepunkt 138 - 139 C (av aceton) 2- (4-bifenylyl)-N- (3 ,4-dimetoksyf enetyl) -N-metyl-ig-ditian-2-propylamin-oksalat (1:1): smeltepunkt 167 - 169 C (av aceton) v ■ . •. • N-(p-klorfenetyl)-N-metyl-2-fenyl-g-ditian-2-propylamin- N-(3,4-dimethoxyphenethyl)-2-(p-fluorophenyl)-N-methyl-m-dithian-2-propylamine hydrochloride: melting point 138 - 139 C (from acetone) 2-(4-biphenylyl)-N - (3,4-dimethoxy enethyl)-N-methyl-ig-dithian-2-propylamine-oxalate (1:1): melting point 167 - 169 C (of acetone) v ■ . •. • N-(p-chlorophenethyl)-N-methyl-2-phenyl-g-dithian-2-propylamine-
hydroklorid: smeltepunkt 145 - 14 7 C (av aceton) ved å gå ut fra 2-fenyl-m-ditian og N-(3-klorpropyl)-4-klor-N-metyl- hydrochloride: melting point 145 - 14 7 C (of acetone) starting from 2-phenyl-m-dithiane and N-(3-chloropropyl)-4-chloro-N-methyl-
fenetylamin phenethylamine
N-metyl-N-fenetyl-2-fgny1-m-ditian-2-propylamin-hydroklorid: N-methyl-N-phenethyl-2-fgny1-m-dithiane-2-propylamine hydrochloride:
smeltepunkt 136 - 137 C (av aceton) ved å gå ut fra 2-fenyl- melting point 136 - 137 C (of acetone) starting from 2-phenyl-
m-ditian og N-(3-klorpropyl)-N-metyl-fenetylamin (kokepunkt 78 - 80°C/0,001 mmHg) m-dithiane and N-(3-chloropropyl)-N-methyl-phenethylamine (boiling point 78 - 80°C/0.001 mmHg)
N-(3,4-dimetoksyfenetyl)-N-metyl-2-fenyl-m-ditian-2-etylamin-hydroklorid: smeltepunkt 172 - 174 C (av aceton) ved å gå ut fra 2-fenyl-m-ditian og N- (2-kloretyl)-3,4-dimetoksy-N-metyl-fenetylamin N-(3,4-dimethoxyphenethyl)-N-methyl-2-phenyl-m-dithiane-2-ethylamine hydrochloride: melting point 172 - 174 C (of acetone) starting from 2-phenyl-m-dithiane and N-(2-chloroethyl)-3,4-dimethoxy-N-methyl-phenethylamine
N- (3 ,4-dimetoksyfenetyl)-N-metyl-2-(2-tienyl)-m-ditian-2-propylamin-hydroklorid: smeltepunkt 138 - 140 C (av aceton) rac-N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N,P-di-metyl-m-ditian-2-propylamin-oksalat(1:1) smeltepunkt 138 - N-(3,4-dimethoxyphenethyl)-N-methyl-2-(2-thienyl)-m-dithian-2-propylamine hydrochloride: melting point 138 - 140 C (from acetone) rac-N-(3,4- dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N,P-dimethyl-m-dithian-2-propylamine-oxalate (1:1) melting point 138 -
139 C (av aceton-eddikester) ved å gå ut fra 2-(3,4-dimetoksyfenyl)-m-ditian og N-(3-klor-2-metylpropyl)-3,4-dimetoksy-N-metylf enetylamin 139 C (of acetone-acetic ester) starting from 2-(3,4-dimethoxyphenyl)-m-dithiane and N-(3-chloro-2-methylpropyl)-3,4-dimethoxy-N-methylphenethylamine
EKSEMPEL 4 EXAMPLE 4
35,2 g 2-(3,4-dimetoksyfenyl)-m-ditian-1,1,3,3-tetraoksyd (fremstilt ifølge eksempel 2) ble suspendert i 180 ml abs. dioksan og tilsatt med 2,53 g natrium. Blandingen kokes under argon i 20 timer, hvorved natriumet går fullstendig i opp-løsning. Deretter tilsettes 27,2 g N-(3-klorpropyl)-3,4-dimetoksy-N-metyl-fenetylamin (fremstilt ifolge eksempel 3) ved romtemperatur, den torre oppløsningen rores 1 time ved romtemperatur og kokes 3 timer ved tilbakelbp. Blandingen helles på is-vann og ekstraheres tre ganger med eddikester. Eddikesterekstraktene forenes og ekstraheres med 1 N HC1 35.2 g of 2-(3,4-dimethoxyphenyl)-m-dithiane-1,1,3,3-tetraoxide (prepared according to Example 2) was suspended in 180 ml of abs. dioxane and added with 2.53 g of sodium. The mixture is boiled under argon for 20 hours, whereby the sodium dissolves completely. Then 27.2 g of N-(3-chloropropyl)-3,4-dimethoxy-N-methyl-phenethylamine (prepared according to example 3) are added at room temperature, the dry solution is stirred for 1 hour at room temperature and boiled for 3 hours at reflux. The mixture is poured onto ice-water and extracted three times with vinegar. The acetic ester extracts are combined and extracted with 1 N HCl
tre ganger. De sure ekstraktene innstilles alkalisk og ekstraheres med kloroform tre ganger. Kloroformekstraktene forenes, vaskes med vann, tørkes med magnesiumsulfat og inndampes. Den krystallinske resten omkrystalliseres i metanol og man erholder krystaller med et smeltepunkt på 143 - 145°C. three times. The acidic extracts are made alkaline and extracted with chloroform three times. The chloroform extracts are combined, washed with water, dried with magnesium sulfate and evaporated. The crystalline residue is recrystallized in methanol and crystals with a melting point of 143 - 145°C are obtained.
For fremstilling av hydrokloridet oppløses basen i aceton To prepare the hydrochloride, the base is dissolved in acetone
og tilsettes et isbad med 20 ml dioksanisk hydrogenklorid. Det krystallinske saltet nutsjes fra og omkrystalliseres av acetonitril-aceton (1:3). Det således erholdte N-(3,4-dimetoksyfenetyl)-2- (3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin-1,1,3,3-tetraoksyd-hydroklorid tørkes natten over i høyvakuum ved 120°C. Man erholder 38,9 g substans med et smeltepunkt på 167 - 169°C. Analyse: and added to an ice bath with 20 ml of dioxanic hydrogen chloride. The crystalline salt is filtered off and recrystallized from acetonitrile-acetone (1:3). The thus obtained N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride is dried overnight in high vacuum at 120°C. 38.9 g of substance with a melting point of 167 - 169°C are obtained. Analysis:
Analogt det som er beskrevet foran kan følgende forbindelser fremstilies: N-(3,4-dimetoksyfenetyl)-N-metyl-2-(2-naftyl)-m-ditian-2-propylamig-1,1,3,3-tetraoksyd-oksalat (1:1): smeltepunkt 190 - 191 C (av aceton-metanol) N-(3,4-dimetoksyfenetyl)-N-metyl-2-(3,4-trimetoksyfenyl)-m-ditian-2-propylamin-l,1.3,3-tetraoksyd-oksalat (1:1): smeltepunkt 146 - 148°C (av aceton-eddikester) 2-(m-bromfenyl)-N-(3,4-dimetoksyfenetyl)-N-metyl-m-ditian-2-propylamin-1,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 158 - 160 C (av metanolisk HC1 og etylacetat) 2- (m-nitrofeny1)-N-(3,4-dimetoksyfenetyl)-N-metyl-m-ditian-2-progylamin-1,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 212 - Analogous to what is described above, the following compounds can be prepared: N-(3,4-dimethoxyphenethyl)-N-methyl-2-(2-naphthyl)-m-dithiane-2-propylamig-1,1,3,3-tetraoxide -oxalate (1:1): melting point 190 - 191 C (of acetone-methanol) N-(3,4-dimethoxyphenethyl)-N-methyl-2-(3,4-trimethoxyphenyl)-m-dithian-2-propylamine -1,1,3,3-tetraoxide-oxalate (1:1): melting point 146 - 148°C (of acetone-acetic ester) 2-(m-bromophenyl)-N-(3,4-dimethoxyphenethyl)-N-methyl- m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: m.p. 158 - 160 C (of methanolic HCl and ethyl acetate) 2-(m-nitrophenyl)-N-(3,4-dimethoxyphenethyl)- N-methyl-m-dithiane-2-progylamine-1,1,3,3-tetraoxide hydrochloride: melting point 212 -
214 (av aceton) 214 (of acetone)
N-(3,4-dimetoksyfenetyl)-2-(p-fluorfenyl)-N-metyl-m-ditian-2-progylamin-1,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 234 - N-(3,4-dimethoxyphenethyl)-2-(p-fluorophenyl)-N-methyl-m-dithiane-2-progylamine-1,1,3,3-tetraoxide hydrochloride: melting point 234 -
236 C (av metanol) 236 C (of methanol)
N- (3,4-dimetoksyfenetyl)-N-metyl-2-fenyl-m-ditian-2-propylamin-1,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 149 C (spaltning) N-(3,4-dimethoxyphenethyl)-N-methyl-2-phenyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point 149 C (decomposition)
(av metanol) (of methanol)
N- (3 ,4-dimetoksyfenetyl)-2- (3,4-dimetoksyfenyl)-N-etyl-rn-ditian-2-pgopylamin-l,1,3,3-tetraoksyd-oksalat (1:1): smeltepunkt 177 - N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-ethyl-rn-dithian-2-pgopyramine-1,1,3,3-tetraoxide-oxalate (1:1): melting point 177 -
179 C (av metanol og aceton) [av 2-(3,4-dimetoksyfenyl)-m-ditian-1,1,3,3-tetraoksyd og N-(3-klorpropyl)-3,4-dimetoksy-N-etyl-fenetylamin] 179 C (from methanol and acetone) [of 2-(3,4-dimethoxyphenyl)-m-dithiane-1,1,3,3-tetraoxide and N-(3-chloropropyl)-3,4-dimethoxy-N- ethyl-phenethylamine]
N- (3,4-dimetoksyfenetyl)-2-(4-isopropylfenyl)-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 225 - N-(3,4-dimethoxyphenethyl)-2-(4-isopropylphenyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point 225 -
227 C (av dioksanisk HCl-eddikester) 227 C (of dioxanic HCl-acetic ester)
N- (3,4-dimetoksyfenetyl)-2- (3-trifluormetyl-fenyl)-N-metyl-m-di ti an-2-propylamin-l ,1,3,3-tetraoksyd-oksalat: smeltepunkt: 128 - 130 C (av aceton) N,2-bis- (3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin-1,1,3,3-tetraoksyd 2- (3,4-dimetoksyfenyl)-N-[4-(3,4-dimetoksyfenyl)-butyl]-m-ditian-2-propylamin-l,1,3,3-tetraoksyd N-(3,4-dimetoksyfenetyl)-N-metyl-2- (3,4-xylyl)-m-ditian-2-propylamin-1,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 176 - 178 C (av acetonitril) 2-(3-butoksy-4-metoksy-f e'ny.l)-N-(3 ,4-dimetoksy-f enetyl)-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd: smeltepunkt: 84 - 85 C (av metanol-isopropyleter) N-(3,4-dimethoxyphenethyl)-2-(3-trifluoromethyl-phenyl)-N-methyl-m-dithane-2-propylamine-1,1,3,3-tetraoxide-oxalate: melting point: 128 - 130 C (from acetone) N,2-bis-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide 2-(3,4-dimethoxyphenyl) -N-[4-(3,4-dimethoxyphenyl)-butyl]-m-dithian-2-propylamine-1,1,3,3-tetraoxide N-(3,4-dimethoxyphenethyl)-N-methyl-2- (3,4-xylyl)-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point 176 - 178 C (from acetonitrile) 2-(3-butoxy-4-methoxy-phenyl)-N-(3,4-dimethoxy-phenyl)-N-methyl-m-dithian-2-propylamine-1,1,3, 3-tetraoxide: melting point: 84 - 85 C (from methanol-isopropyl ether)
N-{3[21 -(3,4-dimetoksy-fenyl)-m-ditian-21-yl]-propylf-N-metyl-1,4-benzodioksan-6-etylamin-l',1',3', 3'-tetraoksyd-hydroklorid: smeltepunkt: 208 - 210 C (av acetonitril) N-{3[21-(3,4-dimethoxy-phenyl)-m-dithian-21-yl]-propyl-N-methyl-1,4-benzodioxane-6-ethylamine-1',1',3' , 3'-tetraoxide hydrochloride: melting point: 208 - 210 C (from acetonitrile)
N-[4-(3,4-dimetoksyfenyl)-butyl]-2-(p-isopropylfenyl)-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid: smeltepunkt: 148 - 150 C (av eddikester-dioksanisk HC1) rac-2- (3,4-dimetoksyfenyl)-N-[3-(3,4-dimetoksyfenyl)-1-metyl-propyl]-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd: smeltepunkt: 115 - 117 C N-[4-(3,4-dimethoxyphenyl)-butyl]-2-(p-isopropylphenyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point: 148 - 150 C (of acetic ester-dioxanic HCl) rac-2-(3,4-dimethoxyphenyl)-N-[3-(3,4-dimethoxyphenyl)-1-methyl-propyl]-N-methyl-m-dithiane -2-propylamine-1,1,3,3-tetraoxide: melting point: 115 - 117 C
N- (3,4-dimetoksyfenetyl)-2-(4-etoksy-3-metoksyfenyl)-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid: smeltepunkt: 180 - 192 C (av acetonitril) m-^2'-/3-[(3,4-dimetoksy-fenetyl)-metylamino]-propyl/-m-ditian-2'-yli-benzonitril-1<1>,1',3',3<1->tetraoksyd-hydroklorid: smeltepunkt: 160°C spaltning N-(3,4-dimethoxyphenethyl)-2-(4-ethoxy-3-methoxyphenyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point: 180 - 192 C (from acetonitrile) m-^2'-/3-[(3,4-dimethoxy-phenethyl)-methylamino]-propyl/-m-dithian-2'-yl-benzonitrile-1<1>,1' ,3',3<1->tetraoxide hydrochloride: melting point: 160°C decomposition
2-(1,4-benzodioksan-6-yl)-N-(3,4-dimetoksyfenetyl)-N-metyl-m-di tian-2-propylamin-l ,1,3,3-tetraoksyd-hydroklorid: smelte- 2-(1,4-benzodioxan-6-yl)-N-(3,4-dimethoxyphenethyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melt -
punkt: 201 - 204 C N-(3,4-dimetoksyfenetyl)-2-(4-metoksy-m-tolyl)-N-metyl-m-di tian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid: smelte- point: 201 - 204 C N-(3,4-dimethoxyphenethyl)-2-(4-methoxy-m-tolyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide -hydrochloride: melt-
punkt 146°C spaltning (av aceton) point 146°C decomposition (of acetone)
m-<^2 ' -/3-/[4- (3 ,4-dimetoksyf enyl) -butyl] -metylamino_/-propy 1/m-ditian-2'-yl^-benzonitril-1',1',3",3<1->tetraoksyd-hydroklorid: smeltepunkt 120 - 122° (av vann) m-<^2' -/3-/[4-(3,4-dimethoxyphenyl)-butyl]-methylamino_/-propyl 1/m-dithian-2'-yl^-benzonitrile-1',1', 3",3<1->tetraoxide hydrochloride: melting point 120 - 122° (of water)
2-(3,4-dimetoksyfenyl)-N-metyl-N-(p-metylfenetyl)-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid: smeltepunkt: 2-(3,4-dimethoxyphenyl)-N-methyl-N-(p-methylphenethyl)-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point:
169 - 171 C (av aceton og eddikester). 169 - 171 C (of acetone and acetic acid).
EKSEMPEL 5 EXAMPLE 5
6,08 g 2-(3,4-metylendioksyfenyl)-m-ditian-1,1,3,3-tetraoksyd (fremstilt ifolge eksempel 2) rores under argon med 25 ml 6.08 g of 2-(3,4-methylenedioxyphenyl)-m-dithiane-1,1,3,3-tetraoxide (prepared according to example 2) is stirred under argon with 25 ml
abs. dimetylformamid og tilsettes 0,8 g av en 55%'ig natrium-hydridsuspensjon. Man lar blandingen reagere en halv time ved romtemperatur og en time ved 40°C. Etter avkjoling på romtemperatur tilsettes 4,8 g N-(3-klorpropyl)-3,4-dimetoksy-N-metyl-fenetylamin (fremstilt ifolge eksempel 3) og blandingen oppvarmes 16 timer ved 100°C. Den avkjolte blandinge helles så på is og ekstraheres tre ganger med eddikester. De organiske ekstraktene vaskes med vann, torkes med magnesiumsulfat og inndampes i vakuum. Den gjenblivende oljen loses i aceton og tilsettes 5 ml av en 6 N dioksanisk hydrogenkloridlosning. Det avnutsjede bunnfallet omkrystalliseres i aceton. Man erholder 7,5 g N-3,4-dimetoksyfenetyl)-N-metyl-2-(3,4-metylendioksyfenyl)-m-ditian-2-propylamin-1,1,3,3-tetraoksyd-hydroklorid med et smeltepunkt på 24 7 - 248°C. abs. dimethylformamide and 0.8 g of a 55% sodium hydride suspension is added. The mixture is allowed to react for half an hour at room temperature and one hour at 40°C. After cooling to room temperature, 4.8 g of N-(3-chloropropyl)-3,4-dimethoxy-N-methyl-phenethylamine (prepared according to example 3) are added and the mixture is heated for 16 hours at 100°C. The cooled mixture is then poured onto ice and extracted three times with vinegar. The organic extracts are washed with water, dried with magnesium sulphate and evaporated in vacuo. The remaining oil is dissolved in acetone and 5 ml of a 6 N dioxanic hydrogen chloride solution is added. The precipitate that is scraped off is recrystallized in acetone. 7.5 g of N-3,4-dimethoxyphenethyl)-N-methyl-2-(3,4-methylenedioxyphenyl)-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride are obtained with a melting point of 24 7 - 248°C.
Analyse: Analysis:
Analogt det som er beskrevet foran kan folgende forbindelser fremstilles: N-(3,4-dimetoksyfenetyl)-N-metyl-2-p-tolyl-m-ditian-2-progylamin-1,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 203 - 207 C (av acetonitril-aceton) Analogously to what is described above, the following compounds can be prepared: N-(3,4-dimethoxyphenethyl)-N-methyl-2-p-tolyl-m-dithian-2-progylamine-1,1,3,3-tetraoxide hydrochloride : melting point 203 - 207 C (of acetonitrile-acetone)
2-(4-benzyloksy)-3-metoksyfenyl-N- (3,4-dimetoksyfenetyl)-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 220 - 221°C (av etanol)' 2-(4-Benzyloxy)-3-methoxyphenyl-N-(3,4-dimethoxyphenethyl)-N-methyl-m-dithiane-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point 220 - 221 °C (of ethanol)'
N-(3,4-dimetoksyfenetyl)-N-metyl-2- (2'-tienyl)-m-ditian-2-progylamin-1,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 179 - 182 C (av aceton) 2- (3 ,4-diklorfenyl) -N- (3 ,4-dimetoksyfenetyl) -N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 175 - 177°C (av metanol) N- (3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-m-di tian-2-etylamin-l,1,3,3-tetraoksyd-oksalat (1:1): smeltepunkt 202 - 204°C (av aceton). N-(3,4-dimethoxyphenethyl)-N-methyl-2-(2'-thienyl)-m-dithian-2-progylamine-1,1,3,3-tetraoxide hydrochloride: melting point 179 - 182 C (off acetone) 2-(3,4-dichlorophenyl)-N-(3,4-dimethoxyphenethyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point 175 - 177 °C (of methanol) N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-ethylamine-1,1,3,3-tetraoxide-oxalate (1:1): melting point 202 - 204°C (of acetone).
EKSEMPEL 6 EXAMPLE 6
10 g 3',4'-dimetoksy-4-(metylveratrylamino)butyrofenon-hydroklorid loses i 50 ml kloroform og tilsettes med 3,25 g 1,3-propanditiol. I blandingen innledes hydrogenklorid ved 10 g of 3',4'-dimethoxy-4-(methylveratrylamino)butyrophenone hydrochloride are dissolved in 50 ml of chloroform and 3.25 g of 1,3-propanedithiol are added. Hydrogen chloride is introduced into the mixture by
romtemperatur. Etter 24 timers henstand helles blandingen på vann, stilles basisk med 3 N natronlut og ekstraheres med eter. Etter torkning og inndampning av losningsmidlet loses den oljeaktige resten i aceton og tilsettes med den ekvivalente mengde vannfri oksalsyre. Det krystallinske bunnfallet omkrystalliseres i aceton. Man erholder 2-(3,4-dimetoksy-fenyl)-N-metyl-N-veratryl-m-ditian-2-propylaninoksalat room temperature. After standing for 24 hours, the mixture is poured into water, made basic with 3 N caustic soda and extracted with ether. After drying and evaporation of the solvent, the oily residue is dissolved in acetone and added with the equivalent amount of anhydrous oxalic acid. The crystalline precipitate is recrystallized in acetone. One obtains 2-(3,4-dimethoxy-phenyl)-N-methyl-N-veratryl-m-dithian-2-propylene oxalate
(1:1) med et smeltepunkt på 133 - 136°C. (1:1) with a melting point of 133 - 136°C.
Analyse: Analysis:
Det som utgangsmateriale anvendte 3<1>,4'-dimetoksy-4-(metyl-veratrylamino) butyrof enon kan fremstilles som folger: The 3<1>,4'-dimethoxy-4-(methyl-veratrylamino) butyrof enone used as starting material can be prepared as follows:
I en 1-liters rundkolbe tilsettes 500 g polyfosforsyre og Add 500 g of polyphosphoric acid and
69 g veratrol. Til dette tilsettes i en porsjon 61 g 4-klorsmorsyre, hvorved temperaturen uavbrutt stiger til 55°C. Etter en time helles hele massen på is. Deretter ekstraheres med en blanding av eter-metylenklorid (3:1). De organiske ekstraktene ekstraheres med vann, så med en mettet natrium-bikarbonatlosning og deretter ennå en gang med vann, torkes med magnesiumsulfat og inndampes i vakuum. Den gjenblivende krystallgroten omkrystalliseres av eter. Man erholder 62,9 69 g of veratrol. To this, 61 g of 4-chlorobutyric acid is added in one portion, whereby the temperature rises continuously to 55°C. After an hour, the entire mass is poured over ice. Then extract with a mixture of ether-methylene chloride (3:1). The organic extracts are extracted with water, then with a saturated sodium bicarbonate solution and then once more with water, dried with magnesium sulfate and evaporated in vacuo. The remaining crystal grain is recrystallized from ether. You get 62.9
g 3,4-dimetoksy-y-klor-butyrofenon med et smeltepunkt på 91 - 92°C. g 3,4-dimethoxy-γ-chloro-butyrophenone with a melting point of 91 - 92°C.
12 g 3,4-dimetoksy-y-klorbutyrofenon tilsettes med 40 ml N-etyl-N,N-diisopropylamin og 9 g N-metylhomoveratrylamin og rores i 6 timer ved 120°C. Etter inndampning av losningsmidlet i vakuum behandles den viskose massen med eter og natronlut. De organiske ekstraktene vaskes med vann og ekstraheres med 1 N HC1. De sure ekstraktene innstilles så alkalisk og ekstraheres med eter. Eterekstraktene forenes, torkes med natriumsulfat og inndampes. Det således erholdte, og ved tynnsjiktskromatografi nesten rene, 3',4'-dimetoksy-4-(metyl-veratrylamino) -butyrofenon kan anvendes uten ytterligere rensning. 12 g of 3,4-dimethoxy-γ-chlorobutyrophenone are added with 40 ml of N-ethyl-N,N-diisopropylamine and 9 g of N-methylhomoveratrylamine and stirred for 6 hours at 120°C. After evaporation of the solvent in a vacuum, the viscous mass is treated with ether and caustic soda. The organic extracts are washed with water and extracted with 1 N HCl. The acidic extracts are then made alkaline and extracted with ether. The ether extracts are combined, dried with sodium sulphate and evaporated. The thus obtained, and by thin-layer chromatography almost pure, 3',4'-dimethoxy-4-(methyl-veratrylamino)-butyrophenone can be used without further purification.
Analogt det foran beskrevne kan folgende forbindelser fremstilles: N- (3,4-dimetoksyfenetyl)-2- (3,4-dimetoksyfenyl)-N-metyl-m-o ditian-2-butylamin-oksalat (1:1) med smeltepunkt 134 - 136 C Analogously to what was described above, the following compounds can be prepared: N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-odithian-2-butylamine oxalate (1:1) with melting point 134 - 136 C
av aceton; of acetone;
ved å gå ut fra by proceeding from
1.3- propanditiol og 5-[(3,4-dimetoksyfenetyl)-metylamino]-3',4'-dimetoksyvalerofenon (smp. for hydrokloridet 165 - 1,3-propanedithiol and 5-[(3,4-dimethoxyphenethyl)-methylamino]-3',4'-dimethoxyvalerophenone (m.p. for the hydrochloride 165 -
166°C) 166°C)
erholdt av obtained by
3.4- dimetoksy-6-klorvalerofenon og N-metylhomoveratrylamin. N- (3,4-dimetoksy-fenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-m-o ditian-2-pentylamin-oksalat (1:1) med smeltepunkt 109 - 111 C av aceton; 3.4-dimethoxy-6-chlorovalerophenone and N-methylhomoveratrylamine. N-(3,4-dimethoxy-phenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-odithian-2-pentylamine-oxalate (1:1) m.p. 109 - 111 C of acetone;
ved å gå ut fra by proceeding from
1,3-propanditiol og 6-[(3,4-dimetoksyfenetyl)-metylamigo]-3 1,4'-dimetoksyheksanofenon (smp. av hydrokloridet 128 - 129 C) erholdt av 1,3-propanedithiol and 6-[(3,4-dimethoxyphenethyl)-methylamigo]-3 1,4'-dimethoxyhexanophenone (m.p. of the hydrochloride 128 - 129 C) obtained by
6-klor-3',4'-dimetoksyheksanofenon og N-metylhomoveratrylamin. 2-(3,4-dimetoksyfenyl)-N-| 3- (3,4-dimetoksyfenyl)-propylj-N-met^l-m-ditian-2-propylamin-oksalat (1:1) med smeltepunkt 116 - 118 C av aceton; 6-chloro-3',4'-dimethoxyhexanophenone and N-methylhomoveratrylamine. 2-(3,4-dimethoxyphenyl)-N-| 3-(3,4-dimethoxyphenyl)-propylj-N-methyl-m-dithian-2-propylamine oxalate (1:1) with melting point 116 - 118 C of acetone;
ved å gå ut fra by proceeding from
1.3- propanditiol og 3 ' ,4 ' -dimetoksy-4— <'[ 3 ,4-dimetoksyf enyl) - propyljmetylaminoj butyrofenon, 1,3-propanedithiol and 3',4'-dimethoxy-4-<'[3,4-dimethoxyphenyl)-propyljmethylaminojbutyrophenone,
erholdt av obtained by
3.4- dimetoksy-y-klorbutyrofenon og 3-(3,4-dimetoksyfenyl)-N-mety1pr opy1ami n. 3,4-dimethoxy-y-chlorobutyrophenone and 3-(3,4-dimethoxyphenyl)-N-methylpropylamine.
2-(3,4-dimetoksyfenyl)-N-metyl-N-(a-metyl-fenetal)-m-ditian-2-propylamin-oksalat (1:1): smeltepunkt 131 - 132 C (av aceton-eddikester); 2-(3,4-dimethoxyphenyl)-N-methyl-N-(a-methyl-phenetal)-m-dithian-2-propylamine-oxalate (1:1): melting point 131 - 132 C (of acetone-acetic ester) ;
ved å gå ut fra by proceeding from
1, 3-propanditiol og 4-[ (3 ,4-dimetoksy-oc-metylfenetyl) -metylamino]-3',4'-dimetoksybutyrofenon, 1, 3-propanedithiol and 4-[(3,4-dimethoxy-oc-methylphenethyl)-methylamino]-3',4'-dimethoxybutyrophenone,
erholdt av obtained by
3,4-dimetoksy-y-klorbutyrofenon og N, a-dimetyl-(3-f enylety lamin (kokepunkt = 130 - 140°/20 mmHg); 3,4-dimethoxy-γ-chlorobutyrophenone and N,α-dimethyl-(3-phenylethylamine) (boiling point = 130 - 140°/20 mmHg);
N- (3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-1,3-ditiolan-2-propylamin-oksalat (1:1) med smeltepunkt 150 - 152 av aceton N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-1,3-dithiolane-2-propylamine oxalate (1:1) with melting point 150 - 152 of acetone
ved å gå ut fra by proceeding from
4-[(3,4-dimetoksyfenetyl)-metylamino]-3',4',-dimetoksybutyro-fenon og 1,2-etanditiol. 4-[(3,4-dimethoxyphenethyl)-methylamino]-3',4',-dimethoxybutyro-phenone and 1,2-ethanedithiol.
EKSEMPEL 7 EXAMPLE 7
10,4 g 2-(3-klorpropyl)-2-(3,4-dimetoksyfenyl)-m-ditian-1,1,3,3-tetraoksyd tilsettes med 5,11 g N-metylhomoveratrylamin, 30 ml N-etyl-N,N-diisopropylamin og 70 ml dimetylformamid• Oppløsningen oppvarmes ved 120°C i løpet av 6 timer. Etter inndampningen bearbeides resten videre analogt eksempel 5. 10.4 g of 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-m-dithiane-1,1,3,3-tetraoxide are added with 5.11 g of N-methylhomoveratrylamine, 30 ml of N-ethyl -N,N-diisopropylamine and 70 ml of dimethylformamide• The solution is heated at 120°C during 6 hours. After evaporation, the residue is further processed analogously to example 5.
Man erholder N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid med et smeltepunkt på 167 - 169°C. N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride is obtained with a melting point of 167 - 169°C.
Analogt det forangående kan følgende forbindelser fremstilles: N-(3,4-dimetoksyfenetyl)-N-metyl-2-fenyl-m-ditian-2-propylamin-1,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 149 C (spaltning) av metanol Analogous to the above, the following compounds can be prepared: N-(3,4-dimethoxyphenethyl)-N-methyl-2-phenyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point 149 C ( cleavage) of methanol
N- (p-klorfenetyl)-N-metyl-2-fenyl-m-ditian-2-gropylamin-l,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 246 - 249 C (spaltning) N-(p-chlorophenethyl)-N-methyl-2-phenyl-m-dithian-2-gropyramine-1,1,3,3-tetraoxide hydrochloride: melting point 246 - 249 C (decomposition)
av metanol-metylenklorid of methanol-methylene chloride
N-metyl-N-fenetyl-2-fenyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 165 - 167°C, av aceton 2- (3 ,4-dime ':oksyfenyl) -N-metyl-N-veratryl-m-ditian-2-propylamin^ 1,1,3,3-tetraoksyd: smeltepunkt 137 - 139 C av aceton-etanol. N- (3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-m-ditian-2-progylamin-1,1,3,3-tetraoksyd-hydroklorid: smeltepunkt 130 - 132 C av aceton. N-methyl-N-phenethyl-2-phenyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride: melting point 165 - 167°C, of acetone 2-(3,4-dime ' :oxyphenyl)-N-methyl-N-veratryl-m-dithian-2-propylamine^ 1,1,3,3-tetraoxide: melting point 137 - 139 C of acetone-ethanol. N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-m-dithian-2-progylamine-1,1,3,3-tetraoxide hydrochloride: melting point 130 - 132 C of acetone.
Det i det forangående som utgangsmateriale anvendte 2- (3-klorpropyl)-2-(3,4-dimetoksyfenyl)-m-ditian-1,1,3,3-tetraoksyd kan fremstilles som følger: 10,9 g 3,4-dimetoksy-y-klorbutyrofenon (fremstilt ifolge eksempel 6) loses i 120 ml kloroform og tilsettes 5 ml 1,3-propanditiol og 1 ml bortrifluorideterat ved romtemperatur. Etter en time ved romtemperatur vaskes kloroformlosni ngen The 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-m-dithiane-1,1,3,3-tetraoxide used in the foregoing as starting material can be prepared as follows: 10.9 g 3,4 -dimethoxy-γ-chlorobutyrophenone (prepared according to example 6) is dissolved in 120 ml of chloroform and 5 ml of 1,3-propanedithiol and 1 ml of boron trifluoride etherate are added at room temperature. After one hour at room temperature, the chloroform solution is washed
tre ganger med vann, tre ganger med 1 N natronlut og ennå three times with water, three times with 1 N caustic soda and again
tre ganger med vann. De organiske faser torkes med magnesium-sulf at og inndampes i vakuum. Den oljeaktige resten oppløses straks i 500 ml kloroform ved 0 - 5°C og tilsettes 45,7 g fast m-klorperbenzosyre, slik at reaksjonstemperaturen ikke overstiger 5°C. Blandingen står så til henstand 64 timer i kjoleskap. Den organiske fasen vaskes tre ganger med 1 N natronlut og tre ganger med vann, torkes med magnesiumsulfat og inndampes i vakuum. Resten omkrystalliseres i metylenklorid/isopropyleter. Man erholder 2-(3-klorpropyl)-2-(3,4-dimetoksyf enyl ) -m-ditian-1 , 1 , 3 , 3-tetraoksyd med et smeltepunkt på 183 - 184°C. three times with water. The organic phases are dried with magnesium sulphate and evaporated in vacuo. The oily residue is immediately dissolved in 500 ml of chloroform at 0 - 5°C and 45.7 g of solid m-chloroperbenzoic acid is added, so that the reaction temperature does not exceed 5°C. The mixture is then allowed to rest for 64 hours in a refrigerator. The organic phase is washed three times with 1 N caustic soda and three times with water, dried with magnesium sulphate and evaporated in vacuo. The residue is recrystallized in methylene chloride/isopropyl ether. 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-m-dithian-1,1,3,3-tetraoxide with a melting point of 183 - 184°C is obtained.
Det i det foranstående likeså som utgangsmateriale anvendte 2- (3-klorpropyl)-2-fenyl-m-ditian-1,1,3,3-tetraoksyd kan fremstilles som folger: 19,63 g 2-fenyl-m-ditian opploses i 300 ml tetrahydrofuran.• Ved -70°C tildryppes langsomt under argon-gassing 43,5 ml av en oppløsning av butyllitium i heksan. Blandingen rores totalt 1 1/2 time ved -20°C. Den erholdte røde løsningen tilsettes en oppløsning av 15,74 g 1,3-bromklorpropan i 250 ml abs. tetrahydrofuran ved -70°C. Den således erholdte oppløsning lar man stå til henstand en time ved -20°C og en time ved romtemperatur. Opplosningsmidlet inndampes i vakuum og den oljeaktige resten opptas i eter. Den eterholdige fasen vaskes med 1 N natronlut og med vann, torkes med magnesiumsulfat og inndampes i vakuum. Det således erholdte 2-(3-klorpropyl)-2-fenyl-m-ditian peroksyderes, som angitt i foregående avsnitt, med m-klorperbenzosyre i kloroform ved 0 - 5°C. Man erholder etter omkrystallisasjon i eddikester 2-(3-klorpropyl)-2-fenyl-m-ditian-1,1,3,3-tetraoksyd med et smeltepunkt på 182°C. The 2-(3-chloropropyl)-2-phenyl-m-dithiane-1,1,3,3-tetraoxide used in the above as starting material can be prepared as follows: 19.63 g of 2-phenyl-m-dithiane is dissolved in 300 ml of tetrahydrofuran.• At -70°C, 43.5 ml of a solution of butyllithium in hexane is slowly added dropwise under argon gassing. The mixture is stirred for a total of 1 1/2 hours at -20°C. A solution of 15.74 g of 1,3-bromochloropropane in 250 ml of abs is added to the red solution obtained. tetrahydrofuran at -70°C. The solution thus obtained is allowed to stand for one hour at -20°C and one hour at room temperature. The solvent is evaporated in vacuo and the oily residue is taken up in ether. The ether-containing phase is washed with 1 N sodium hydroxide solution and with water, dried with magnesium sulphate and evaporated in vacuo. The 2-(3-chloropropyl)-2-phenyl-m-dithiane thus obtained is peroxidized, as indicated in the previous section, with m-chloroperbenzoic acid in chloroform at 0 - 5°C. After recrystallization in acetic ester, 2-(3-chloropropyl)-2-phenyl-m-dithiane-1,1,3,3-tetraoxide with a melting point of 182°C is obtained.
EKSEMPEL 8 EXAMPLE 8
3,76 g 2-(3,4-dimetoksyfenyl)-2-(2,3-epoksypropyl)-m-ditian- 3.76 g 2-(3,4-dimethoxyphenyl)-2-(2,3-epoxypropyl)-m-dithian-
1,1,3,3-tetraoksyd oppvarmes med 50 ml etanol, 30 ml kloroform og 1,95 g N-metylhomo-varatrylamin i 18 timer under argon ved tilbakelop. Etter avdampningen av losningsmidlet kromatograferes resten på silikagel med kloroform-etanol (98:2). Den erholdte oljen loses i aceton og tilsettes med ekvivalente mengder vannfri oksalsyre. Bunnfallet filtreres fra og omkrystalliseres med metanol-aceton. Det erholdte rac.-a-[(3,4-dimetoksyfenetyl)-metylamino]-metyl-2-(3,4-dimetoksyfenyl)-m-ditian-2-etanol-l,1,3,3-tetraoksyd-oksalat (1:1) krystalliserer med 1 mol aceton og smelter ved 162 - 164°C. 1,1,3,3-tetraoxide is heated with 50 ml of ethanol, 30 ml of chloroform and 1.95 g of N-methylhomovaratrylamine for 18 hours under argon at reflux. After evaporation of the solvent, the residue is chromatographed on silica gel with chloroform-ethanol (98:2). The oil obtained is dissolved in acetone and equivalent amounts of anhydrous oxalic acid are added. The precipitate is filtered off and recrystallized with methanol-acetone. There was obtained rac.-α-[(3,4-dimethoxyphenethyl)-methylamino]-methyl-2-(3,4-dimethoxyphenyl)-m-dithiane-2-ethanol-1,1,3,3-tetraoxide-oxalate (1:1) crystallizes with 1 mol of acetone and melts at 162 - 164°C.
Analyse: Analysis:
Det som utgangsmateriale anvendte 2-(3,4-dimetoksyfenyl)-2-(2,3-epoksypropyl)-m-ditian-1,1,3,3-tetraoksyd kan frem- The 2-(3,4-dimethoxyphenyl)-2-(2,3-epoxypropyl)-m-dithiane-1,1,3,3-tetraoxide used as starting material can produce
stilles som folger: set as follows:
9,6 g 2-(3,4-dimetoksyfenyl)-m-ditian-1,1,3,3-tetraoksyd (fremstilt ifolge eksempel 2) opploses i 35 ml dimetylformamid 9.6 g of 2-(3,4-dimethoxyphenyl)-m-dithiane-1,1,3,3-tetraoxide (prepared according to example 2) is dissolved in 35 ml of dimethylformamide
og tilsettes under omrbring under argon, ved romtemperatur med 1,2 g natriumhydrid. Suspensjonen rores i ennå 1/2 and added with stirring under argon, at room temperature with 1.2 g of sodium hydride. The suspension is stirred for another 1/2
time ved 40°C, deretter avkjbles den og tilsettes 2,8 g epiklorhydrin. Deretter oppvarmes blandingen 16 timer på hour at 40°C, then it is cooled and 2.8 g of epichlorohydrin are added. The mixture is then heated for 16 hours
100°C. Etter avkjbling på romtemperatur helles suspensjonen på vann og det oljeaktige materialet ekstraheres med kloroform. Etter inndampning av losningsmidlet kromatograferes resten 100°C. After cooling to room temperature, the suspension is poured onto water and the oily material is extracted with chloroform. After evaporation of the solvent, the residue is chromatographed
på silikagel med kloroform-etanol (98:2). Det erholdte 2-(3,4-dimetoksyfenyl)-2-(2,3-epoksypropyl)-m-ditian-1,1,3,3- on silica gel with chloroform-ethanol (98:2). The obtained 2-(3,4-dimethoxyphenyl)-2-(2,3-epoxypropyl)-m-dithiane-1,1,3,3-
tetraoksyd omkrystalliseres av metylenklorid-etanol og har et smeltepunkt på 175 - 176°C. tetraoxide is recrystallized from methylene chloride-ethanol and has a melting point of 175 - 176°C.
EKSEMPEL 9 EXAMPLE 9
3,65 g 2-(3-klorpropyl)-2-(3,4-dimetoksyfenyl)-m-ditian-1,3-dioksyd, 7,8 g N-metylhomoveratrylamin og 20 ml dimetylsulfoksyd oppvarmes under argon i 16 timer på 50°C. Deretter helles opplbsningen i 200 ml vann og stilles sterkt alkalisk. 3.65 g of 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-m-dithiane-1,3-dioxide, 7.8 g of N-methylhomoveratrylamine and 20 ml of dimethylsulfoxide are heated under argon for 16 hours on 50°C. The solution is then poured into 200 ml of water and made strongly alkaline.
Det overskytende N-metylhomoveratrylamin ekstraheres med eter. The excess N-methylhomoveratrylamine is extracted with ether.
Den alkaliske oppløsningen ekstraheres så med metylenklorid. Metylenkloridekstraktene torkes over magnesiumsulfat. Etter avdampningen av losningsmidlet opptas resten i aceton og tilsettes med dioksanisk hydrogenklorid (til pH 2). Den krystallinske resten omkrystalliseres av aceton-acetonitril og man erholder N-(3,4-dimetoksyfenetyl) —2-(3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin-l,3-dioksyd-hydroklorid: smeltepunkt 148 - 14 9°C. (diastereomer-blanding). The alkaline solution is then extracted with methylene chloride. The methylene chloride extracts are dried over magnesium sulfate. After evaporation of the solvent, the residue is taken up in acetone and dioxanic hydrogen chloride is added (to pH 2). The crystalline residue is recrystallized from acetone-acetonitrile and N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithiane-2-propylamine-1,3-dioxide hydrochloride is obtained : melting point 148 - 14 9°C. (mixture of diastereomers).
Det som utgangsmateriale anvendte 2-(3-klorpropyl)-2-(3,4-dimetoksyf enyl)-m-ditian-1,3-dioksyd kan fremstilles som folger: 76,9 g 2-(3,4-dimetoksyfenyl)-m-ditian (fremstilt ifolge eksempel 1) opploses i 900 ml abs. tetrahydrofuran, oppløs-ningen avkjøles på -70°C og tilsettes så med 128 ml av en butyllitiumoppløsninge slik at temperaturen ikke overstiger -60°C. Blandingen holdes så 2 timer ved -20°C, hvorved det dannes et bunnfall. Deretter avkjøles igjen på -70°C og det tilsettes 47,3 g 1,3-bromklorpropan i 750 ml abs. tetrahydrofuran. Blandingen holdes så 1 time ved -20°C og en time ved romtemperatur. Deretter avdampes tetrahydrofuranet, resten opptas i eter og ekstraheres. Etter avdampningen av løsnings-midlet erholder man 2-(3-klorpropyl)-2-(3-dimetoksyfenyl)-m-ditianet. The 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-m-dithiane-1,3-dioxide used as starting material can be prepared as follows: 76.9 g of 2-(3,4-dimethoxyphenyl) -m-dithiane (prepared according to example 1) is dissolved in 900 ml abs. tetrahydrofuran, the solution is cooled to -70°C and then added with 128 ml of a butyllithium solution so that the temperature does not exceed -60°C. The mixture is then kept for 2 hours at -20°C, whereby a precipitate is formed. It is then cooled again at -70°C and 47.3 g of 1,3-bromochloropropane in 750 ml abs is added. tetrahydrofuran. The mixture is then kept for 1 hour at -20°C and one hour at room temperature. The tetrahydrofuran is then evaporated, the residue taken up in ether and extracted. After evaporation of the solvent, 2-(3-chloropropyl)-2-(3-dimethoxyphenyl)-m-dithiane is obtained.
55,25 g 2-(3-klorpropyl )-2-(3 ,4-dimetoksyf enyl)-m-ditian opploses i 500 ml iseddik. Under omrøring ved 5°c tildrypper man i løpet av 2 timer en oppløsning av 34 g 30%'ig hydrogenperoksyd i 300 ml iseddik. Blandingen står til henstand i 60 timer ved romtemperatur og konsentreres deretter i vakuum ved 40°C. Dissolve 55.25 g of 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-m-dithiane in 500 ml of glacial acetic acid. While stirring at 5°C, a solution of 34 g of 30% hydrogen peroxide in 300 ml of glacial acetic acid is added dropwise over the course of 2 hours. The mixture is allowed to stand for 60 hours at room temperature and is then concentrated in vacuo at 40°C.
Den erholdte oljen kromatograferes på 1,5 kg silikagel med kloroform-etanol, først 98:2, og så 95:5. Man erholder etter omkrystallisasjon i acetonitril 2-(3-klorpropyl)-2-(3,4-dimetoksyf enyl)-m-ditian-1, 3-dioksyd : smeltepunkt 163 - 164°C, (diastereomer-blanding). The oil obtained is chromatographed on 1.5 kg of silica gel with chloroform-ethanol, first 98:2, and then 95:5. It is obtained after recrystallization in acetonitrile 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-m-dithiane-1,3-dioxide: melting point 163 - 164°C, (mixture of diastereomers).
EKSEMPEL 10 EXAMPLE 10
Analogt eksempel 8 kan, ved å gå ut fra 2-(3,4-dimetoksyfenyl)-2-(2,3-epoksypropyl)-m-ditian og N-metylhomoveratrylamin Analogous to example 8, by starting from 2-(3,4-dimethoxyphenyl)-2-(2,3-epoxypropyl)-m-dithiane and N-methylhomoveratrylamine
rac. -ct-[ (3 ,4-dimetoksyfenetyl) -metylamino] -metyl-2- (3 ,4-dimetoksyfenyl)-m-ditian-2-etanol fremstilles. Det tilsvarende hydrobromidet krystalliserer av acetonitril-eddikester og smelter ved 97 - 99°C. rac. -ct-[(3,4-dimethoxyphenethyl)-methylamino]-methyl-2-(3,4-dimethoxyphenyl)-m-dithian-2-ethanol is prepared. The corresponding hydrobromide crystallizes from acetonitrile-acetic ester and melts at 97 - 99°C.
Det som utgangsmateriale anvendte 2- (3,4-dimetoksyfenyl)-2-(2,3-epoksypropyl)-m-ditianet kan analogt eksempel 9, ved å The 2-(3,4-dimethoxyphenyl)-2-(2,3-epoxypropyl)-m-dithiane used as starting material can, analogously to example 9, by
gå ut fra 2-(3,4-dimetoksyfenyl)-m-ditian (fremstilt ifolge eksempel 1) , under anvendelse av epiklorhydrin i stedet for 1,3-bromklorpropan, erholdes. starting from 2-(3,4-dimethoxyphenyl)-m-dithiane (prepared according to example 1), using epichlorohydrin instead of 1,3-bromochloropropane, is obtained.
EKSEMPEL 11 EXAMPLE 11
3,4 g litiumaluminiumhydrid i 60 ml tetrahydrofuran oppvarmes til tilbakelbp. Derpå tilsettes dråpevis 14,7 g N-(3,4-dimetylfenetyl)-2- (3,4-dimetoksyfenyl)-m-ditian-2-propionamid i 80 ml tetrahydrofuran. Den erholdte suspensjonen oppvarmes ennå 3 timer ved tilbakeløp, avkjbles så på 0°C og tilsettes forsiktig med 50 ml mettet natriumsulfatlosning. Det hele nutsjes fra, oppløsningen fortynnes med vann og ekstraheres med eter. De eterholdige ekstraktene vaskes med 1 N natronlut, 3.4 g of lithium aluminum hydride in 60 ml of tetrahydrofuran are heated to reflux. 14.7 g of N-(3,4-dimethylphenethyl)-2-(3,4-dimethoxyphenyl)-m-dithiane-2-propionamide in 80 ml of tetrahydrofuran are then added dropwise. The resulting suspension is heated for a further 3 hours at reflux, then cooled to 0°C and carefully added with 50 ml of saturated sodium sulphate solution. The whole is filtered off, the solution is diluted with water and extracted with ether. The ethereal extracts are washed with 1 N caustic soda,
så med vann, torkes med magnesiumsulfat og inndampes. Den oljeaktige resten kromatograferes på silikagel med kloroform-etanol (95:5). Den erholdte basen loses i aceton og tilsettes ekvivalente mengder vannfri oksalsyre. Det dannede bunnfallet omkrystalliseres av metanol-aceton. Det således erholdte N-(3,4-dimetoksyfenetyl)- 2-(3,4-dimetoksyfenyl)-m-ditian-2-propylamin-oksalat (1:1) smelter ved 186 - 188°C. so with water, dried with magnesium sulphate and evaporated. The oily residue is chromatographed on silica gel with chloroform-ethanol (95:5). The base obtained is dissolved in acetone and equivalent amounts of anhydrous oxalic acid are added. The precipitate formed is recrystallized from methanol-acetone. The N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-m-dithian-2-propylamine oxalate (1:1) thus obtained melts at 186 - 188°C.
Analyse: Analysis:
Det som utgangsmateriale anvendte N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-m-ditian-2-propionamid kan fremstilles som folger: 50 g 3-veratroylpropionsyre i 400 ml kloroform og 22,7 g 1,3-propanditiol tilsettes under omrøring inntil metning med hydrogenklorid. Etter 3 timer ved romtemperatur inndampes opp- losningen til 50 ml og fortynnes med eter. Den tilsvarende losningen ekstraheres tre ganger med 5%'ig natriumkarbonat. The N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-m-dithian-2-propionamide used as starting material can be prepared as follows: 50 g of 3-veratroylpropionic acid in 400 ml of chloroform and 22.7 g 1,3-propanedithiol is added while stirring until saturation with hydrogen chloride. After 3 hours at room temperature, evaporated the solution to 50 ml and dilute with ether. The corresponding solution is extracted three times with 5% sodium carbonate.
De basiske fasene forenes, innstilles surt med konsentrert saltsyre. Det utfelte produktet ekstraheres med eter-metylenklorid 1:3. De organiske ekstraktene torkes og inndampes. The basic phases are combined, made acidic with concentrated hydrochloric acid. The precipitated product is extracted with ether-methylene chloride 1:3. The organic extracts are dried and evaporated.
Resten omkrystalliseres av etanol og man erholder 2-(3,4-dimetoksyfenyl)-m-ditian-2-propionsyre med et smeltepunkt på 134 - 135°c. The residue is recrystallized from ethanol and 2-(3,4-dimethoxyphenyl)-m-dithian-2-propionic acid with a melting point of 134 - 135°c is obtained.
13,2 g 2-(3,4-dimetoksyfenyl)-m-ditian-2-propionsyre, 4 g trietylamin og 180 ml tetrahydrofuran avkjoles på 0°C og tilsettes dråpevis 5,44 g klormaursyreisobutylester i 80 ml tetrahydrofuran i lopet av 10 minutter. Deretter holdes blandingen i 3 timer,ved romtemperatur og tilsettes så ved 0°C 7,25 g homoveratrylamin i 40 ml tetrahydrofuran. Suspensjonen står til henstand 48 timer ved 3°C, inndampes så, tilsettes vann og ekstraheres med eter-metylenklorid 3:1. De eterholdige ekstraktene vaskes med vann, natriumbikarbonat, 13.2 g of 2-(3,4-dimethoxyphenyl)-m-dithian-2-propionic acid, 4 g of triethylamine and 180 ml of tetrahydrofuran are cooled at 0°C and 5.44 g of chloroformate isobutyl ester in 80 ml of tetrahydrofuran are added dropwise over the course of 10 minutes. The mixture is then kept for 3 hours at room temperature and 7.25 g of homoveratrylamine in 40 ml of tetrahydrofuran are then added at 0°C. The suspension is allowed to stand for 48 hours at 3°C, then evaporated, water is added and extracted with ether-methylene chloride 3:1. The ethereal extracts are washed with water, sodium bicarbonate,
1 N vinsyre og vann. Den organiske fasen torkes med magnesium-sulf at og inndampes. Resten krystalliseres av metylenklorid-eter ved 0°C. Man erholder N-(3,4-dimetyloksyfenetyl)-2-(3,4-dimetoksyfenyl )-m-ditian-2-propionamid med.ét 'smeltepunkt på 1 N tartaric acid and water. The organic phase is dried with magnesium sulphate and evaporated. The residue is crystallized from methylene chloride-ether at 0°C. One obtains N-(3,4-dimethyloxyphenethyl)-2-(3,4-dimethoxyphenyl)-m-dithian-2-propionamide with a melting point of
135 - 136°C. 135 - 136°C.
Analogt det foran beskrevne kan N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-m-diti an-2-propylamin-hydrobromid fremstilles. Smeltepunkt 170 - 172°C av etanol. Analogously to what was described above, N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithiane-2-propylamine hydrobromide can be prepared. Melting point 170 - 172°C of ethanol.
EKSEMPEL 12 EXAMPLE 12
0,5 g 2-;/3-[2"-(3,4-dimetoksyfenyl)-m-ditian-2"-yl]-propyl7-metylaminoj-31,4'-dimetoksyacetofenon-1",1",3",3"-tetraoksyd opploses i 15 ml etanol og 30 ml tetrahydfofuran og tilsettes 50 mg natriumborhydrid. Etter 16 timers omroring tilsettes blandingen 15 ml 1 N HC1 og deretter 12 ml 1 N NaOH. Tetra-hydrof uranet avdampes og resten ekstraheres med metylenklorid. 0.5 g 2-;/3-[2"-(3,4-dimethoxyphenyl)-m-dithian-2"-yl]-propyl7-methylaminoj-31,4'-dimethoxyacetophenone-1",1",3 ",3"-tetraoxide is dissolved in 15 ml of ethanol and 30 ml of tetrahydrofuran and 50 mg of sodium borohydride is added. After stirring for 16 hours, 15 ml of 1 N HCl and then 12 ml of 1 N NaOH are added to the mixture. The tetrahydrofuran is evaporated and the residue extracted with methylene chloride.
De organiske ekstraktene vaskes med vann, torkes med magnesiumsulfat og inndampes i vakuum. De erholdte krystallene omkrystalliseres i metanol og man erholder 0,3 g a-r^//3-[ 2'- (3 ,4-dimetoksyfenyl)-m-ditian-2'-ylJpropyl/metylaminq7metyl^ veratryl- The organic extracts are washed with water, dried with magnesium sulphate and evaporated in vacuo. The crystals obtained are recrystallized in methanol and 0.3 g of a-r^//3-[ 2'-(3,4-dimethoxyphenyl)-m-dithian-2'-yl]propyl/methylamineq7methyl^ veratryl-
alkohol-1',1',3',3'-tetraoksyd. Smeltepunkt : 132.- 133°C. alcohol 1',1',3',3'-tetraoxide. Melting point: 132.- 133°C.
Det som utgangsmateriale anvendte 2-'/3-[2"-(3,4-dimetoksyfenyl)-m-ditian-2"-yl]-propyl/-metylaminoj-3',4'-dimetoksyacetofenon-1",1",3",3"-tetraoksyd kan erholdes ved omsetning av 2-(3-klorpropyl)-2-(3,4-dimetoksyfenyl)-m-ditian-1,1,3,3-tetraoksyd og tu-metylamino-3,4-dimetoksyacetofenon: smeltepunkt: 140°C spaltning (av aceton). The starting material used 2-'/3-[2"-(3,4-dimethoxyphenyl)-m-dithian-2"-yl]-propyl/-methylaminoj-3',4'-dimethoxyacetophenone-1",1" ,3",3"-tetraoxide can be obtained by reacting 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-m-dithiane-1,1,3,3-tetraoxide and tu-methylamino-3 ,4-dimethoxyacetophenone: melting point: 140°C decomposition (of acetone).
EKSEMPEL 13 EXAMPLE 13
10 g N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-m-di tian-2-pentylamin (fremstilt ifolge eksempel 6) opploses i 50 ml iseddik og behandles ved romtemperatur med 20 ml 30%'ig hydrogenperoksyd. Etter 3 timer oppvarmes blandingen 3 timer på 35°C og deretter 18 timer på 40°C. Oppløsningen helles så på vann, innstilles basisk med natriumhydroksyd og ekstraheres med metylenklorid. Etter fjerning av opplosningsmidlet kromatograferes resten på silikagel med en blanding av kloroform-metanol-mettet ammoniak (97:3). Det.erholdte produktet opploses i aceton og tilsettes den ekvivalente mengde oksalsyre. Det dannede bunnfall omkrystalliseres av aceton-metanol. Man erholder N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl ) -N-metyl-m-ditian-2-pentylamin-l ,1,3,3-tetraoksyd-oksalat (1:1) med et smeltepunkt på 189 - 191°C. 10 g of N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-pentylamine (prepared according to example 6) are dissolved in 50 ml of glacial acetic acid and treated at room temperature with 20 ml of 30% hydrogen peroxide. After 3 hours, the mixture is heated for 3 hours at 35°C and then for 18 hours at 40°C. The solution is then poured into water, made basic with sodium hydroxide and extracted with methylene chloride. After removal of the solvent, the residue is chromatographed on silica gel with a mixture of chloroform-methanol-saturated ammonia (97:3). The product obtained is dissolved in acetone and the equivalent amount of oxalic acid is added. The precipitate formed is recrystallized from acetone-methanol. N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-pentylamine-1,1,3,3-tetraoxide-oxalate (1:1) is obtained with a melting point of 189 - 191°C.
Analyse: Analysis:
Analogt det foranstående kan følgende forbindelser fremstilles: N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-butylamin-l,1,3,3-tetraoksyd-oksalat med et smeltepunkt på 161 - 163 C (av aceton-metanol), (base 123 - 126°C av etanol), Analogous to the above, the following compounds can be prepared: N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-butylamine-1,1,3,3-tetraoxide- oxalate with a melting point of 161 - 163 C (from acetone-methanol), (base 123 - 126°C from ethanol),
vsd å gå ut fra vsd to proceed from
N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-m-di tian-2-butylamin (fremstilt ifølge eksempel 6) 2- (3,4-dimetoksyfenyl)-N-[3-(3,4-dimetoksyfenyl)-propyl]-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydrobromid, med et smeltepunkt på 138 - 140 C av acetonitril-eddikester, ved å gå ut fra N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-butylamine (prepared according to Example 6) 2-(3,4-dimethoxyphenyl)-N- [3-(3,4-dimethoxyphenyl)-propyl]-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrobromide, with a melting point of 138 - 140 C of acetonitrile-acetic ester , by starting from
2- (3,4-dimetoksyfenyl)-N-[3-(3,4-dimetoksyfenyl)-propyl]-N-metyl-m-ditian-2-propylamin (fremstilt ifolge eksempel 6), rac. -N- (3,4-dimetoksyf enetyl) -2- (3 ,4-dimetoksyfenyl) -N, (3-dimetyl-m-ditian-2-propylamin-l^l,3,3-tetraoksyd-hydroklorid med et smeltepunkt på 183 - 185 C (av aceton-eddikester), 2-(3,4-dimethoxyphenyl)-N-[3-(3,4-dimethoxyphenyl)-propyl]-N-methyl-m-dithian-2-propylamine (prepared according to Example 6), rac. -N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N,(3-dimethyl-m-dithian-2-propylamine-1^1,3,3-tetraoxide hydrochloride with a melting point of 183 - 185 C (of acetone-acetic ester),
ved å gå ut fra by proceeding from
rac. -N- (3 ,4-dimetoksyfenetyl) - 2- (3 ,4-dimetoksyfenyl) -N,(3-dimetyl-m-ditian-2-propylamin (fremstilt ifolge eksempel 3). 2-(3,4-dimetoksyfenyl)-N-metyl-N-(a-metyl-fenetyl)-m-ditian-2-propylamin-l,1,3,3-tetraoksyd-hydroklorid med et smeltepunkt på 185 - 187 C (av aceton-eddikester), rac. -N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N,(3-dimethyl-m-dithian-2-propylamine (prepared according to example 3). 2-(3,4-dimethoxyphenyl )-N-methyl-N-(α-methyl-phenethyl)-m-dithian-2-propylamine-1,1,3,3-tetraoxide hydrochloride with a melting point of 185 - 187 C (of acetone-acetic ester),
ved å gå ut fra by proceeding from
2-(3,4-dimetoksyfenyl)-N-metyl-N-(a-metyl-fenetyl)-m-ditian-2-propylamin (fremstilt ifolge eksempel 6). 2-(3,4-dimethoxyphenyl)-N-methyl-N-(α-methyl-phenethyl)-m-dithian-2-propylamine (prepared according to Example 6).
EKSEMPEL 14 EXAMPLE 14
11,2 g 2-[4- (benzyloksy)-3-metoksyfenyl]-N- (3,4-dimetoksyfenetyl) -N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd (fremstilt ifolge eksempel 5) oppvarmes med 100 ml 48%'ig bromhydrogensyre 2 minutter på dampbadet. Den vandige losningen ekstraheres så med eter, inndampes i vakuum og destilleres azeotropt med etanol-benzen tre ganger. Resten krystalliseres av aceton. Den således erholdte krystallinske massen omkrystalliseres tre ganger av metanol-acetonitril og man erholder 4-{ 21-[3-<(3,4-dimetoksyfenetyl)-metylamino propyl]-m-ditian-2'-ylj-2-metoksyfenol-l' ,1' ,3' ,3'-tetraoksyd-hydro-bromid med et smeltepunkt på 192°C (spaltning). 11.2 g of 2-[4-(benzyloxy)-3-methoxyphenyl]-N-(3,4-dimethoxyphenethyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide ( prepared according to example 5) is heated with 100 ml of 48% hydrobromic acid for 2 minutes in the steam bath. The aqueous solution is then extracted with ether, evaporated in vacuo and distilled azeotropically with ethanol-benzene three times. The residue is crystallized from acetone. The crystalline mass thus obtained is recrystallized three times from methanol-acetonitrile and 4-{21-[3-<(3,4-dimethoxyphenethyl)-methylamino propyl]-m-dithian-2'-ylj-2-methoxyphenol-1 is obtained ',1',3',3'-tetraoxide hydrobromide with a melting point of 192°C (decomposition).
C25 H35 N08 S2-HBr C25 H35 N08 S2-HBr
På analog måte kan ved å gå ut fra 2-[3-(benzyloksy)-3-metoksy-fenyl j-N-(3,4-dimetoksyfenetyl)-N-metyl-m-ditian-2-propylamin-1,1,3,3-tetraoksyd 5—^2 ' -/3-[ (3,4-dimetoksyfenetyl)-metylamino]-propyl7-m-ditian-2' -yl]--2-metoksyfenyl-1' ,1' ,3' ,3'-tetraoksyd-hydrobromid fremstilles: smeltepunkt: 201°C spaltning (av acetonitril) . In an analogous way, starting from 2-[3-(benzyloxy)-3-methoxy-phenyl j-N-(3,4-dimethoxyphenethyl)-N-methyl-m-dithian-2-propylamine-1,1,3 ,3-tetraoxide 5-^2' -/3-[(3,4-dimethoxyphenethyl)-methylamino]-propyl7-m-dithian-2'-yl]--2-methoxyphenyl-1' ,1' ,3' ,3'-tetraoxide hydrobromide is prepared: melting point: 201°C decomposition (of acetonitrile).
EKSEMPEL 15 EXAMPLE 15
2 g 5-^2'-/3-[ (3,4-dimetoksyfenetyl)metylamino]propyl/-m-ditian-2'-ylj -2-metoksyfenol-1',1',3',3'-tetraoksyd opploses i absolutt pyridin og tilsettes med et overskudd eddiksyre-anhydrid. Etter 16 timer ved romtemperatur inndampes oppløs-ningsmidlet og resten kromatograferes på silikagel. 5-^2'-/3-[3, [(3,4-dimetoksyfenetyl)metylamino]propyl/-m-ditian-2'- yll - 2-metofenylacetat-1' ,11 ,3', 3 '-tetraoksyd erholdes samen tykk olje. 2 g 5-[2'-[3-[(3,4-dimethoxyphenethyl)methylamino]propyl[-m-dithian-2'-yl]-2-methoxyphenol-1',1',3',3'-tetraoxide dissolved in absolute pyridine and added with an excess of acetic anhydride. After 16 hours at room temperature, the solvent is evaporated and the residue is chromatographed on silica gel. 5-^2'-/3-[3,[(3,4-dimethoxyphenethyl)methylamino]propyl/-m-dithian-2'-yl-2-methophenylacetate-1',11,3',3'-tetraoxide a thick oil is obtained.
Analyse: Analysis:
EKSEMPEL 16 EXAMPLE 16
0,3 g 2-(3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin-1,1,3,3-tetr aoksyd tilsettes 0,16 g 3 ,4-dimetoksy-j3-f enyletyl-klorid, 5 ml N,N-diisopropyl-N-etylamin og 1,5 ml dimetylformamid og oppvarmes 16 timer ved 130°C. Oppløsningen fordeles så mellom vann og eddikester. Resten kromatograferes på silikagel og man erholder N-(3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd: smeltepunkt: 144°C (av metanol). 0.3 g of 2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide is added to 0.16 g of 3,4-dimethoxy-j3-f phenylethyl chloride, 5 ml of N,N-diisopropyl-N-ethylamine and 1.5 ml of dimethylformamide and heated for 16 hours at 130°C. The solution is then distributed between water and vinegar. The residue is chromatographed on silica gel and N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide is obtained: melting point : 144°C (of methanol).
Det som utgangsmateriale anvendte 2-(3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin-l,1,3,3-tetraoksyd kan fremstilles som folger. The 2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamine-1,1,3,3-tetraoxide used as starting material can be prepared as follows.
3,95 g 2-(3-klorpropyl)-2-(3,4-dimetoksyfenyl)-m-ditian-1,1,3,3-tetraoksyd opploses i 50 ml dimetylformamid. Oppløsningen av-kjøles på 0°C og tilsettes 15 g metylamin. Det oppvarmes 18 timer ved 40°C under trykk. Oppløsningen konsentreres så og krystallgroten omkrystalliseres av litt metanol. Man erholder det ovennevnte produktet med et smeltepunkt: 164°C. 3.95 g of 2-(3-chloropropyl)-2-(3,4-dimethoxyphenyl)-m-dithiane-1,1,3,3-tetraoxide are dissolved in 50 ml of dimethylformamide. The solution is cooled to 0°C and 15 g of methylamine are added. It is heated for 18 hours at 40°C under pressure. The solution is then concentrated and the crystal grain is recrystallized from a little methanol. The above-mentioned product with a melting point of 164°C is obtained.
EKSEMPEL 17 EXAMPLE 17
1 g N- (3,4-dimetoksyfenetyl)-2-(3,4-dimetoksyfenyl)-m-ditian-2-propylamin (fremstilt ifolge eksempel 11) opploses i 20 ml abs. pyridin og tilsettes 200 ml eddiksyre-anhydrid. Etter 18 timer konsentreres opplosningsmidlet, resten fordeles mellom eter og natriumkarbonat (5%). Etter inndampning av losningsmidlet erholder man en olje (1,2 g), hvilken opploses i 20 ml abs. tetrahydrofuran. Denne opplesningen tildryppes langsomt 1 g of N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-m-dithian-2-propylamine (prepared according to example 11) is dissolved in 20 ml abs. pyridine and 200 ml of acetic anhydride are added. After 18 hours, the solvent is concentrated, the residue is distributed between ether and sodium carbonate (5%). After evaporation of the solvent, an oil (1.2 g) is obtained, which is dissolved in 20 ml abs. tetrahydrofuran. This reading is infused slowly
til en suspensjon av 0,4 g litiumaluminiumhydrid og 20 ml abs. tetrahydrofuran. Blanéingen tilsettes med en konsentrert, van-dig natriumsulfatlosning og nutsjes så fra. Etter inndampning av opplosningsmidlet fordeles resten mellom eter og vann og de organiske ekstraktene opparbeides. Den oljeaktige resten behandles med oksalsyre i aceton-eddikester, hvorved N-(3,4-dimetoksyfenetyl)-2- (3,4-dimetoksyfenyl)-N-etyl-m-ditian-2-propylamin-1,1,3,3-tetraoksydoksalat krystalliserer ut: smeltepunkt 126 - 127°C. to a suspension of 0.4 g of lithium aluminum hydride and 20 ml of abs. tetrahydrofuran. The blanéing is added with a concentrated, aqueous sodium sulphate solution and then removed. After evaporation of the solvent, the residue is distributed between ether and water and the organic extracts are worked up. The oily residue is treated with oxalic acid in acetone-acetic ester, whereby N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-ethyl-m-dithian-2-propylamine-1,1,3, 3-Tetraoxyoxalate crystallizes out: melting point 126 - 127°C.
EKSEMPEL 18 EXAMPLE 18
1 g homoveratrumsyre opploses i 15 ml abs. tetrahydrofuran og tilsettes med 0,15 g trietylamin.. Ved 0 - 5°C tildryppes 0,72 g klormaursyre-isobutylester langsomt og blandingen omrores en time ved 5 - 10°C. Til dette drypper man en opp-løsning av 1,63 g 2-(3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin [fremstilt analogt eksempel 16 av 2-(y-klorpropyl)-2-(3,4-dimetoksyfenyl)-m-ditian og metylaminj i 5 ml tetrahydrofuran. Blandingen står til henstand natten over ved romtemperatur. Etter inndampning av losningsmidlet fordeles resten mellom 1 N saltsyre og eter. De organiske ekstraktene vaskes med 5%'ig natriumkarbonatopplosning og vann. Etter torkning med magnesiumsulfat konsentreres opplosningsmidlet. Den oljeaktige resten (1,5 g) opploses i 15 ml tetrahydrofuran og tildryppes en suspensjon av 0,15 g litiumaluminiumhydrid under tilbakelop og argon. Blandingen kokes 2 timer og tilsettes så langsomt med en konsentrert natriumsulfat-opplosning i vann og så med IO ml metylenklorid. Blandingen nutsjes fra og oppløsningen konsentreres. Resten kromatograferes på silikagel og man erholder N-(3,4-dimetoksyfenetyl )-2-(3,4-dimetoksyfenyl)-N-metyl-m-ditian-2-propylamin i form av en tykk olje. Dissolve 1 g homoveratric acid in 15 ml abs. tetrahydrofuran and add 0.15 g of triethylamine. At 0 - 5°C, 0.72 g of chloroformic acid isobutyl ester is slowly added dropwise and the mixture is stirred for one hour at 5 - 10°C. A solution of 1.63 g of 2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamine [prepared analogously to example 16 from 2-(γ-chloropropyl)-2- (3,4-dimethoxyphenyl)-m-dithiane and methylamine in 5 ml of tetrahydrofuran. The mixture is allowed to stand overnight at room temperature. After evaporation of the solvent, the residue is distributed between 1 N hydrochloric acid and ether. The organic extracts are washed with 5% sodium carbonate solution and water. After drying with magnesium sulfate, the solvent is concentrated. The oily residue (1.5 g) is dissolved in 15 ml of tetrahydrofuran and a suspension of 0.15 g of lithium aluminum hydride is added dropwise under reflux and argon. The mixture is boiled for 2 hours and then added slowly with a concentrated sodium sulphate solution in water and then with 10 ml of methylene chloride. The mixture is decanted and the solution is concentrated. The residue is chromatographed on silica gel and N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithian-2-propylamine is obtained in the form of a thick oil.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO752888A NO752888L (en) | 1973-12-21 | 1975-08-20 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1803073A CH611614A5 (en) | 1973-12-21 | 1973-12-21 | Process for the preparation of heterocyclic compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
NO744615L NO744615L (en) | 1975-07-21 |
NO142669B true NO142669B (en) | 1980-06-16 |
NO142669C NO142669C (en) | 1980-09-24 |
Family
ID=4429892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO744615A NO142669C (en) | 1973-12-21 | 1974-12-20 | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE, HETEROCYCLIC COMPOUNDS |
Country Status (24)
Country | Link |
---|---|
JP (1) | JPS595594B2 (en) |
AT (5) | AT344693B (en) |
AU (1) | AU511714B2 (en) |
BE (1) | BE823625A (en) |
CA (4) | CA1057295A (en) |
CH (3) | CH611614A5 (en) |
DD (1) | DD116829A5 (en) |
DE (2) | DE2460593C3 (en) |
DK (1) | DK148323C (en) |
ES (5) | ES433172A1 (en) |
FI (1) | FI67216C (en) |
FR (1) | FR2255064B1 (en) |
GB (3) | GB1489086A (en) |
HK (1) | HK43380A (en) |
HU (1) | HU170429B (en) |
IE (1) | IE40788B1 (en) |
IL (3) | IL46146A (en) |
LU (1) | LU71530A1 (en) |
NL (1) | NL158496B (en) |
NO (1) | NO142669C (en) |
PH (3) | PH19393A (en) |
SE (2) | SE415763B (en) |
YU (1) | YU39311B (en) |
ZA (1) | ZA747526B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2515173A1 (en) * | 1981-10-28 | 1983-04-29 | Delalande Sa | 3-Methoxy 4-alkoxy benzaldehyde(s) - useful as intermediates for antibacterials, esp. trimethoprim and tetroxoprim |
JPS60142297U (en) * | 1984-02-29 | 1985-09-20 | 株式会社豊田自動織機製作所 | Rotating device for swiveling driver's seat in forklift |
JPS62171328U (en) * | 1986-04-23 | 1987-10-30 | ||
DE3642331A1 (en) * | 1986-12-11 | 1988-06-23 | Basf Ag | BASICLY SUBSTITUTED PHENYL ACETONITRILES, THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THEM |
US5434179A (en) * | 1989-06-06 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Method for improving brain function using cholinesterase-inhibiting aminoketone compounds |
AU2002367425B2 (en) * | 2001-12-28 | 2006-03-09 | Takeda Pharmaceutical Company Limited | Preventives/remedies for urinary disturbance |
US20100137403A1 (en) * | 2008-07-10 | 2010-06-03 | Scott Malstrom | Method for enhancing cognition or inhibiting cognitive decline |
-
1973
- 1973-12-21 CH CH1803073A patent/CH611614A5/en not_active IP Right Cessation
-
1974
- 1974-07-19 PH PH20012A patent/PH19393A/en unknown
- 1974-11-25 ZA ZA00747526A patent/ZA747526B/en unknown
- 1974-11-28 IL IL46146A patent/IL46146A/en unknown
- 1974-12-05 FI FI3527/74A patent/FI67216C/en active
- 1974-12-09 IE IE2531/74A patent/IE40788B1/en unknown
- 1974-12-17 PH PH16639A patent/PH13326A/en unknown
- 1974-12-18 CA CA216,313A patent/CA1057295A/en not_active Expired
- 1974-12-18 YU YU3368/74A patent/YU39311B/en unknown
- 1974-12-18 NL NL7416507.A patent/NL158496B/en not_active IP Right Cessation
- 1974-12-19 LU LU71530A patent/LU71530A1/xx unknown
- 1974-12-19 DD DD183214A patent/DD116829A5/xx unknown
- 1974-12-19 SE SE7416086A patent/SE415763B/en not_active IP Right Cessation
- 1974-12-19 DK DK668174A patent/DK148323C/en not_active IP Right Cessation
- 1974-12-20 NO NO744615A patent/NO142669C/en unknown
- 1974-12-20 GB GB55146/74A patent/GB1489086A/en not_active Expired
- 1974-12-20 DE DE2460593A patent/DE2460593C3/en not_active Expired
- 1974-12-20 GB GB23144/77A patent/GB1489087A/en not_active Expired
- 1974-12-20 JP JP49145875A patent/JPS595594B2/en not_active Expired
- 1974-12-20 HU HUHO1757A patent/HU170429B/hu unknown
- 1974-12-20 DE DE2463173A patent/DE2463173C2/en not_active Expired
- 1974-12-20 AT AT1022674A patent/AT344693B/en not_active IP Right Cessation
- 1974-12-20 BE BE151729A patent/BE823625A/en not_active IP Right Cessation
- 1974-12-20 ES ES433172A patent/ES433172A1/en not_active Expired
- 1974-12-20 GB GB23143/77A patent/GB1489088A/en not_active Expired
- 1974-12-23 FR FR7442521A patent/FR2255064B1/fr not_active Expired
-
1976
- 1976-09-01 ES ES451137A patent/ES451137A1/en not_active Expired
- 1976-09-01 ES ES451134A patent/ES451134A1/en not_active Expired
- 1976-09-01 ES ES451135A patent/ES451135A1/en not_active Expired
- 1976-09-01 ES ES451136A patent/ES451136A1/en not_active Expired
-
1977
- 1977-07-19 PH PH20013A patent/PH13396A/en unknown
- 1977-08-29 IL IL52844A patent/IL52844A0/en unknown
- 1977-08-29 IL IL52843A patent/IL52843A0/en not_active IP Right Cessation
-
1978
- 1978-01-06 AU AU32242/78A patent/AU511714B2/en not_active Expired
- 1978-01-19 AT AT38978A patent/AT350053B/en not_active IP Right Cessation
- 1978-01-19 AT AT38878A patent/AT349013B/en not_active IP Right Cessation
- 1978-01-19 AT AT39178A patent/AT349014B/en not_active IP Right Cessation
- 1978-01-19 AT AT38778A patent/AT349012B/en not_active IP Right Cessation
- 1978-04-27 SE SE7804879A patent/SE434746B/en not_active IP Right Cessation
- 1978-06-15 CH CH654178A patent/CH620921A5/en not_active IP Right Cessation
- 1978-06-15 CH CH654078A patent/CH620920A5/en not_active IP Right Cessation
-
1979
- 1979-03-26 CA CA324,132A patent/CA1072966A/en not_active Expired
- 1979-03-26 CA CA324,130A patent/CA1086320A/en not_active Expired
- 1979-03-26 CA CA324,131A patent/CA1079290A/en not_active Expired
-
1980
- 1980-08-14 HK HK433/80A patent/HK43380A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0178874B1 (en) | Alkylsulfonamidophenylalkylamines | |
EP0001900B1 (en) | 9-thia-12-azaprostanoic acid derivatives and compositions containing them | |
NO167947B (en) | TAPE OR PLATE RECORDING STORAGE DEVICE | |
PL147258B1 (en) | Method of obtaining novel sulfonylophenylalkylamines | |
PL71423B1 (en) | Alkanolamine Derivatives[GB1199037A] | |
SK281184B6 (en) | Substituted sulphonamides, pharmaceutical compositions based thereon and process for their preparation | |
NO141687B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-OXO-2,2-DISUBSTITUTED-5-INDANYLOXY-ACETIC ACIDS | |
NO142669B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE, HETEROCYCLIC COMPOUNDS | |
US4073797A (en) | Sulphur containing derivatives | |
US3200151A (en) | Arylaminoalkyl guanidines | |
HU197723B (en) | Process for production of derivatives of substituated amin-methil-5,6,7,8-tetrahydro-oxi-acetic acid and medical preparatives containing them | |
US4902698A (en) | Benzenesulphonamidopyridyl compounds which are useful as thromboxane A.sub.2 | |
NO752888L (en) | ||
US4127588A (en) | Sulphur containing derivatives | |
SK282423B6 (en) | Benzenesulphonamide derivatives, method for their preparation, medicament and pharmaceutical composition containing them | |
US3997608A (en) | N-substituted-dihydroxyphenethylamines | |
EP0043736A1 (en) | Propanolamine derivatives, their salts, processes for preparation and pharmaceutical compositions | |
EP0132267B1 (en) | Aromatic amines | |
JPS63203672A (en) | Novel heterocyclic compound | |
JPH0567619B2 (en) | ||
DK166820B1 (en) | METHOD FOR PREPARING 1- (2,6-DIMETHYLPHENOXY) -2-AMINOPROPAN OR ANY ACID ADDITION SALT FROM 2,6-DIMETHYLPHENOL | |
CH620922A5 (en) | Process for the preparation of sulphur-containing heterocyclic compounds | |
NO131594B (en) | ||
NO120583B (en) | ||
NO122649B (en) |